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In recent years, the incidence of non-communicable diseases (NCD) normally associated with 
advanced age has begun presenting in younger populations. This has resulted in a growing 
burden on global healthcare systems and decreasing quality of life in individuals. 
Cardiovascular diseases, cancers, chronic respiratory diseases, chronic inflammatory diseases 
and diabetes are some of the many NCD’s and all these have two maladaptive characteristics 
in common, namely chronic low-grade inflammation and increased oxidative stress. The aim 
of this research was to identify a threshold prior to maladaptation in both redox and 
inflammatory status which can be targeted with preventative medicine strategies; in this way, 
we may identify suitable models which are sensitive enough to identify this threshold as well 
as show small effect sizes so that they can be used for drug screening of preventative 
medicine treatments.  
In order to elucidate this threshold, two rodent models were employed to simulate a pre-
onset and an early onset state. The pre-onset state was simulated by chronic D-galactose 
injections to mimic cumulative oxidative stress as is associated with chronological ageing. The 
early onset state was simulated with a collagen induced rheumatoid arthritis (RA) model. A 
grape seed polyphenol supplementation was employed to assess the sensitivity of the 
models. Comprehensive end-point analysis of the oxidative and inflammatory state of various 
compartments were performed. Analysis of parameters associated with ageing were also 
included as measure of relative ageing status in models. 
The results of both studies indicated that the threshold or point of onset of accelerated ageing 
was indeed identified. In the D-galactose model, a novel finding was the compromised 
antioxidant capacity in plasma, even in the absence of experimentally elevated oxidative 
damage, observed as decreases in plasma FRAP. However, oxidative damage was observed in 
tissue specific investigations, such a morphological changes in the mesenteric lymph nodes. 
In the RA model, decreases in antioxidant capacity was noted along with oxidative damage in 
plasma, but not in all tissue types investigated - particularly the brain. This novel finding of 
pre-damage oxidative changes in the brain was indicated by decreases in MDA and increases 
in FRAP. This combined with a switch to a pro-inflammatory state within the circulation, 
confirms the early disease state within the RA model.  
This investigation has elucidated the importance of monitoring the oxidative state within 
multiple compartments to identify the threshold at which disturbances to homeostasis turns 
into maladaptation and FRAP may be the most sensitive parameter to display this. The effect 
changes noted after supplementation with an antioxidant treatment also enhanced our 
knowledge of which parameters and tissue are susceptible to oxidative and inflammatory 




Die insidensie van nie-aanmeldbare siektes (NAS) wat normaalweg met gevorderde 
ouderdom verbind word, het meer onlangs ook begin presenter in jonger populasies. Hierdie 
tendens veroorsaak ‘n groeiende las op die gesondheidstelsels en verlaag lewenskwaliteit. 
Kardiovaskulêre siekte, kanker, kroniese respiratoriese siekte en diabetes is van die NAS en 
het almal twee kenmerke van wanaanpassing in gemeen, naamlik laegraad inflammasie en 
verhoogde oksidatiewe stres. Die doel van hierdie navorsing was om die drumpel voor 
wanaanpassing te identifiseer, waar beide redoks en inflammatoriese status geteiken kan 
word met voorkomende medisyne strategieë;  sodoende kan ons geskikte modelle 
identifiseer wat sensitief genoeg is om hierdie drumpel uit te wys en ook klein effekte op te 
tel sodat hierdie modelle gebruik kan word vir middeltoetsing van voorkomende medisynes.  
Ten einde hierdie drumpel te belig, is twee knaagdiermodelle gebruik om 
wanaanpassingsgebeure voor siekte, asook vroeg in die proses, te simuleer. Die voor-siekte 
toestand is gesimuleer deur kroniese D-galaktose inspuitings om kumulatiewe oksidatiewe 
stress – en dus versnelde veroudering – te veroorsaak. Die vroeë siektetoestand is gesimuleer 
in ‘n kollageen-geïnduseerde model van rumatoïede artritis (RA). ‘n Druifpit-polifenool 
supplement is gebruik om die sensitiwiteit die model te toets.  Omvattende eindpunt analise 
van oksidatiewe en inflammatoriese status in verskeie kompartemente is uitgevoer. ‘n Analise 
van parameters wat met veroudering verband hou, is ook ingesluit om die relatiewe toestand 
van veroudering te belig.    
Resultate dui aan dat die drumpel waar versnelde veroudering begin, suksesvol aangedui is. 
‘n Nuwe bevinding in die D-galaktose model, is die verswakte anti-oksidant kapasiteit selfs in 
die afwesigheid van eksperimentele verhoogde oksidatiewe skade, soos aangedui deur die 
verlaagde plasma FRAP. Oksidatiewe skade is egter wel opgemerk in weefsel-spesifieke 
ondersoeke, bv. die morfologiese veranderinge in die mesenteriese limfnodes. In die artritis 
model is verlaagde anti-oksidant kapasiteit saam met oksidatiewe skade in plasma opgemerk, 
maar nie in alle weefsels nie – veral die brein.  Hierdie nuwe bevinding van redoks 
veranderinge voordat skade opgemerk word in die brein, word ondersteun deur verlaagde 
MDA en verhoodge FRAP vlakke, en saam met die skuif na ‘n pro-inflammatoriese status in 
sirkulasie, bevestig huidige data die vroeg-siekte status in die RA model. 
Hierdie ondersoeke illustreer die belang van monitering van die oksidatiewe stress status in 
verskeie kompartemente, om die drumpel waar versteurings in homeostase na 
wanaanpassing verander, aan te dui. FRAP blyk die mees sensitiewe merker in hierdie verband 
te wees. Effekte van die supplement dra by tot ons kennis in terme van weefsel-verskille in 
terme van hul kwesbaarheid vir oksidatiewe en inflammatoriese modulasie, en waar terapie 
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Table 2.1. Representative studies, drawing a parallel between a normal aged 
phenotype and those reported in populations with chronic diseases. Note: CD’s-
conjugated dienes, MPO-myeloperoxidase , PI3K- Phosphoinositide 3-kinases, 
MDA-malondialdehyde, IL-6- interleukin 6, TAS-total antioxidant status, H2O2- 
hydrogen peroxide, O2- - superoxide radical, SOD- superoxide dismutase, NO-nitric 
oxide, CRP- C-reactive protein, ESR- erythrocyte sedimentation rate, DMPD- N,N-
dimethyl-p-phen- ylenediamine, FRAP-ferric reducing antioxidant power, CAT- 
catalase, GSHx- glutathione peroxidase, hsCRP- High sensitivity C-reactive protein, 
GSSG:GSH- reduced glutathione/oxidized glutathione ratio, TNF-α- Tumor necrosis 
factor-alpha, GR- glutathione reductase, TAC-total antioxidant capacity, 8-iso-
PGF2α-8-iso-prostaglandin F2α, TNF-RI- Tumor necrosis factor receptor 1, IL-1β-
Interleukin 1 beta, IL-17-interluekin-17, IL-10-interleukin-10. 
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Table 2.2. Representative summary demonstrating various animal models which 
mimic chronic disease or accelerated ageing, and which have reported benefits of 
phytomedicine interventions in the context of redox and/or inflammatory profile. 
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Figure 5.1: FRAP assay measuring antioxidant capacity in the plasma, Data shown 
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Chapter 1: Background and rationale 
1.1 Introduction  
In recent years non-communicable disease has become an increasing burden on global 
healthcare systems.  In 2015, the World Health Organisation predicated that most countries 
would fail to meet global targets on addressing non-communicable diseases (NCDs) – which 
were outlined by the second Global Status Report on Noncommunicable Diseases of 2014 –  
by the 2025 target (Mendis et al., 2015; Damasceno, 2016). Non-communicable diseases have 
become the leading causes of death and currently prescribed preventative strategies do not 
seem to be ameliorating the problem (Torabi et al., 2016). 
The most common NCDs are cardiovascular diseases, cancers, chronic respiratory diseases, 
chronic inflammatory diseases and diabetes. One of the underlying causalities of many of 
these diseases is the interconnected and self-propagating cycle of sterile inflammation and 
oxidative stress, two systems activated and maintained by the modern lifestyle. Poor dietary 
choices, sedentary lifestyle, psychological stress and increased exposure to pollution has 
resulted in excessive stimulation of these two systems, resulting in a phenotype characterised 
by chronic low grade inflammation and poor redox status (Juster et al., 2010; Fernández-
Sánchez et al., 2011; Kennedy et al., 2014). The increasing stressors of the modern lifestyle 
have caused a phenomenon that can be termed as accelerated ageing due to the fact that the 
above-mentioned diseases are occurring at earlier stages of life and affecting pre-geriatric 
populations (Smith, 2018). Investigating the role of inflammatory and oxidative stress driven 
maladaptation is imperative to enhancing our understanding of the gradual transition from 
allostatic load, to exhaustion of endogenous protective counter-regulatory systems and 
predisposition to clinical onset of chronic disease.  
This gradual process, which presents as a phenotype resembling premature ageing – or 
accelerated ageing – is a particular focus of this thesis, as it represents the threshold between 
a normal and pathological phenotype. Thus, since it is my interest to prevent disease, the 
ability to move this threshold so that disease onset may be delayed or prevented, is a major 
focus in the studies presented in this thesis. 
In terms of identifying this threshold, it is known that chronic low-grade inflammation and 
cumulative oxidative stress result from consistent load on the systems which are employed 
to regulate homeostasis (Valko et al., 2007; Pomatto and Davies, 2018). Unfortunately, the 
threshold at which these maladaptations become irreversible are unknown thus far. 
Identification, or characterisation of this threshold, is a major gap in existing literature which 
needs to be addressed, so that preventative strategies may be assessed in terms of their 
capacity to delay crossing of this “ageing-threshold”(Cohen, 2018).   
Important requirements for such a tool, is that it should present a physiologically relevant 
simulation of pre-pathology states, while being sufficiently sensitive to detect the small effect 
size changes and maladaptations that are usually not clinically visible. In other words, 




reversible, will allow investigations into early maladaptive mechanisms to target even before 
overt signs of damage are observed. In the relevant literature to date, the majority of animal 
disease simulations are severe in order to increase the effect size measured and thus the 
statistical power, and thus cannot accurately simulate chronic, low grade accumulation of 
maladaptive changes. Of course, models of natural ageing have been employed, but the time 
and resources required impede the number and depth of studies. 
In terms of preventative strategies, potential treatments should ideally be sufficiently potent 
to aid endogenous counter-systems, while being mild enough to not result in unanticipated, 
lasting changes which may have downstream effects on other systems (Nobili et al., 2009; 
Smith, 2018). In this niche, many phytomedicines are being investigated for efficacy as daily 
disease prevention (anti-ageing) supplements (Liu et al., 2018). For the purpose of this thesis, 
I have selected one such phytomedicine which is well-researched in this context, in order to 
assess the sensitivity of the models designed. 
The layout of this thesis is as follows: in the next chapter, I present an overview of the most 
relevant published literature. In the next two chapters, I present data in the form of two 






Chapter 2: Literature review 
2.1 Introduction  
The pressures of modern society increase the number of adverse stimuli that individuals are 
exposed to on a regular basis. These range from sedentary lifestyles and unhealthy diets to 
increasing psychological stress and anxiety, all of which lead to cumulative oxidative stress 
and persisting low grade inflammation (Petersen, 2016). This in turn results in a chronically 
maladapted phenotype characterised by increased oxidative damage and inefficient immune 
responses which are characteristically similar to a geriatric phenotype (Belsky, 2015; 
Benayoun, 2015).  The occurrence of this status, first described at cellular level by Hayflick in 
1965 (Hayflick, 1965), was therefore termed accelerated ageing. Senescent cellular 
phenotypes share many characteristics with cellular phenotypes identified in numerous 
diseases and conditions normally associated with advanced age, but which are now reported 
with increasing incidence in younger populations affected by certain conditions (Smith, 2009; 
Belsky, 2015; Liu, 2015; Mercado, 2015; Xu, 2018). In addition to predisposing individuals for 
pathologies such as  cardiovascular disease, diabetes and even neuroinflammation (Karam, 
2017; Powrie, 2018), emerging evidence suggests that this maladapted phenotype may be 
transferred epigenetically to subsequent generations (Moisiadis, 2017; Adams, 2019; Chang, 
2019). This underlines the importance of developing preventative strategies with which to 
address the phenomenon of accelerated ageing.  
This review provides evidence of an accelerated ageing phenotype across the majority of 
modern chronic diseases, followed by a critical assessment of the most pertinent obstacles 
preventing implementation of preventative medicine strategies, including those delaying 
preventative drug discovery research. In addition, an overview of cellular processes at play in 
promoting or delaying ageing via modulating redox and/or inflammatory status is provided, 
in order to elucidate cellular therapeutic targets of current supplementation strategies.  
2.2 The accelerated ageing profile in clinical disease 
The gradual development of an pro-inflammatory phenotype with advancing age, or as result 
of accelerated ageing in the aetiology of chronic disease as result of endocrine contributors – 
such as glucocorticoid resistance and decline of dehydroepiandrosterone (which has known 
antioxidant and anti-inflammatory effects) – was recently reviewed (Powrie and Smith 2018) 
and is not a focus in this review.  
Rather, this review will focus on the allostatic effect of persistent activation of the 
inflammatory immune system and overabundance of free radicals, leading to unfavourable 
redox status, which appears omnipresent in modern chronic diseases and resembles a 
prematurely aged phenotype. 
In this context, ample evidence for an aged phenotype in chronic disease has been presented 
in the published literature. In Table 2.1, using representative studies, we draw a parallel 
between a normal aged phenotype and those reported in chronologically younger 




chronic disease is clearly highlighted. Thus, the significant benefit to longer term clinical 
outcome via intervention to prevent redox and inflammatory dysregulation and thus delay 
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and women 
44.4 ± 9.8 
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Table 2.1. Representative studies, I draw a parallel between a normal aged phenotype and those 
reported in populations with chronic diseases. Note: CD’s-conjugated dienes, MPO-myeloperoxidase 
, PI3K- Phosphoinositide 3-kinases, MDA-malondialdehyde, IL-6- interleukin 6, TAS-total antioxidant 
status, H2O2- hydrogen peroxide, O2- - superoxide radical, SOD- superoxide dismutase, NO-nitric oxide, 
CRP- C-reactive protein, ESR- erythrocyte sedimentation rate, DMPD- N,N-dimethyl-p-phen- 
ylenediamine, FRAP-ferric reducing antioxidant power, CAT- catalase, GSHx- glutathione peroxidase, 
hsCRP- High sensitivity C-reactive protein, GSSG:GSH- reduced glutathione/oxidized glutathione ratio, 
TNF-α- Tumor necrosis factor-alpha, GR- glutathione reductase, TAC-total antioxidant capacity, 8-iso-
PGF2α-8-iso-prostaglandin F2α, TNF-RI- Tumor necrosis factor receptor 1, IL-1β-Interleukin 1 beta, IL-





2.3 Why preventative medicine? 
Many people do not realise that they have an underlying low-grade, but cumulative, 
inflammatory, or redox-related maladaptation until diagnosed with a disease. At that point, 
adaptation had already progressed to a stage of sufficient allostatic load for disease to 
manifest clinically and the body’s endogenous antioxidant and/or anti-inflammatory 
mechanisms have been exhausted and are unable to effectively counter the disruption of 
homeostasis (Powrie, 2018). Given this relatively late stage at which patients usually present 
at medical practitioners, modern medicine is often based on symptomatic treatment which 
commences after clinical disease onset. While these therapeutic strategies provide 
symptomatic relief, very few succeed in correcting the dysregulation which resulted in disease 
onset. If the original aetiological factors such as oxidative stress and chronic inflammation are 
not addressed and allowed to maladapt irrevocably one becomes predisposed to developing 
a number of co-morbidities that share these aetiological factors. The addition of co-
morbidities results in further complications for the primary pathology and long-term 
exposure to negative side effects associated with treating multiple conditions. The result is 
decreased quality as well as quantity of life of patients (Mikuls, 2003; Martin-Ruiz, 2014; 
Barnes, 2015; Scuric, 2017).  
Furthermore, although medical practitioners do prescribe additional, vital strategies such as 
dramatic lifestyle changes and dietary improvements, which in fact could also have delayed 
disease onset if instituted timeously, compliance is generally relatively poor (Ganiyu, 2013; 
Abel Tibebu, Daniel Mengistu, 2017; Bhawana Sharma and Mukta Agrawal, 2017; Leung, 
2017; Lee, 2018). Furthermore, the western lifestyle is associated with significant 
psychological stress - as evidenced by the increased incidence of modern chronic diseases as 
result of urbanisation (Ramachandran, 2008; Smith, 2009; Isaksson, 2015; González, 2017) - 
which contributes substantially to allostatic load. Given the significant occupation-associated 
pressure on especially economically active age groups, it is near impossible to avoid stress 
exposure. The recent COVID-19 pandemic highlighted an extreme form of uncontrollable 
psychological stress exposure, hitting home the requirement for external assistance to 
prevent unavoidable stressors from manifesting as accelerated ageing-associated pathology.  
Given the relative non-compliance to current behaviour- or lifestyle changing strategies, it 
may be more realistic to rather aim applied health research to disease prevention using daily 
supplements to counter the maladaptation caused by unhealthy human behaviour. Indeed, 
there is a global trend towards increased preventative supplement use, in particular in the 
stress-relief and antioxidant niches (Y. J. Zhang, 2015). Unfortunately, the majority of 
supplement products on the shelves remain scientifically unvalidated, despite emerging 
evidence of significant toxicity risk especially in the context of antioxidant overdose (Rietjens, 
2002; Hart, 2012; Cásedas, 2018). In particular in the niche of phytomedicine supplements, 
research is not always aimed at understanding mechanisms, but more often limited to 
superficial in vitro efficacy testing, so that little quality data is available on actual mechanisms 




(Taylor, 2001). An unfortunate tendency in the phytomedicine literature is large scale in vitro 
screening and reporting of potential benefits of plant extracts, without follow-up research to 
advance to in vivo models, and a relative lack of publication of “negative data”. This has 
resulted in the phytomedicine literature to be cluttered by seemingly positive in vitro results 
lacking in vivo confirmation/refutation.  
For preventative medicine to succeed at ground level, a system is required which is driven by 
qualified personnel, such as primary care nurses or medical practitioners; of course, these 
individuals need to have access to up-to-date science-based support of in vivo efficacy for 
products across a variety of illnesses and chronic conditions. Without this information, it is 
difficult to advance preventative medicine to a formalised strategy within healthcare systems. 
In my opinion, this is a significant gap in especially the preventative phytomedicine niche 
which requires urgent attention, as relatively uninformed consumers are currently left to 
“fend for themselves”, which of course poses a risk of unanticipated adverse effects, 
especially when supplement compounding is performed by the layperson, who operates 
under the assumption that anything “natural” is safe (Güney, 2019).  
The key priority should be to establish suitable models with which to investigate mechanisms 
of maladaptation and thereby identify therapeutic targets. Importantly, in order to advance 
drug discovery in phytomedicine from bench to bedside, it is vital to simulate the turning 
point in the allostasis trajectory where adaptation changes into maladaptation and 
predisposition to disease. Only such models will enable accurate assessment of potential 
benefit or risk associated with new potential preventative medicines. Identifying changes in 
mechanisms may also elucidate accurate and feasible biomarkers which can both identify at 
risk persons and which are sensitive enough to reflect preventative treatment efficacy.  
Furthermore, given the omnipresence of inflammation and oxidative stress in modern chronic 
disease, characterisation of models in terms of inflammatory and redox profile will lend itself 
to broad application in the drug discovery niche. 
2.4 A requirement for suitable pre-clinical models 
As stated, an obstacle in the training of health care professionals in the preventative 
prescription and use of (antioxidant) phytomedicines, is probably the lack of definitive 
positive clinical data from human studies relative to the large and fast-growing body of 
evidence from cellular and animal studies (Steinhubl, 2008). One of the main reasons for 
many preventative and plant medicinal strategies not being successfully translated in human 
clinical trials, may be ascribed to the fact that the maladaptive “rate of departure” from 
normal during allostasis (McEwen, 1998) – and thus the measurable effect size in shorter term 
intervention studies – is relatively small when considered in conjunction with the relatively 
larger inter-individual and intra-individual variability expected in regulatory system 
parameters, such as the ones most relevant to accelerated ageing (Smith, 2018).   
Research has shown that advanced non-clinical analytical methodology is required in order to 




where testing is done in normal individuals changes are unlikely to show large effects in the 
preventative niche, simply because effect size is nearly non-existent (Smith, 2018). These 
types of studies are relatively sparse, which warrants the use of a somewhat more 
standardisable in vivo model.  
Animal models in particular may be more feasible tools with which to investigate long-term 
outcome, as well as to elucidate the mechanisms of action and specific molecular targets 
affected by preventative treatments. Indeed, in more standardised systems such as animal 
and cell culture models, larger effect changes may be simulated and contribution of 
confounding factors – of which diet is a significant one – may be largely eliminated. An added 
advantage of these models is that they allow for more comprehensive investigations at tissue 
level than what is usually feasible in a human cohort, so that investigations may extend to 
more than just the circulatory compartment. Furthermore, given the relatively shorter total 
lifespan of small animals when compared to that of humans, longitudinal studies across a 
lifespan or substantial part (Leenaars, 2019) thereof – which is particularly relevant to the 
topic of accelerated ageing – are much more feasible in animals than humans (Holsapple, 
2003; Sengupta, 2013). As such, animal models may provide important information that 
cannot be generated in humans within a reasonable time frame.   In the context of 
inflammation and redox-associated research, animal models are particularly feasible, as the 
processes of inflammation and redox regulation are highly conserved across species (Barth, 
2019; Patil, 2019). 
Given these benefits, models of maladapted inflammatory and/or redox profiles are clearly 
most suitable as research tools in the context of accelerated ageing. However, before data 
generated from pre-clinical models can be evaluated in the context of prevention of 
accelerated ageing, and before a suitable model may be selected for drug testing, it is 
necessary to understand the nature and pattern of deviation from normal, of the most 
pertinent cellular and molecular pathways which determine nett redox and inflammatory 
status(Cohen, 2018). The following paragraphs will describe the gradual change from 
adaptation to pre-pathology which precedes several modern pathologies, which may be 
addressed by preventative approaches aimed at attenuating oxidative stress and/or chronic 
low-grade inflammation. 
2.5 Accelerated ageing mechanisms 
Oxidative stress is characterised by  an excess of free radicals both within the cell and in the 
extracellular space (Valko, 2007). This is the result of not only production of higher levels of 
free radicals, but also down-regulation of the signalling systems initiating antioxidant 
responses (Aycicek, 2005).Especially in the modern, westernised society, many contributing 
factors jointly facilitate increased production of free radicals.   
2.5.1 Increased levels of free radicals 




In terms of exogenous contribution to oxidative stress, modern society unfortunately offers 
plenty of sources. Firstly, exposure to increasing amounts and variants of pollution may 
stimulate endogenous systems to create free radicals which cause cellular stress to the 
organism. Air pollution has been linked to increases in incidence of various diseases such as 
cancers, cardiovascular disease, Alzheimer’s disease and chronic obstructive pulmonary 
disease, where onset and progression are attributed to chronic exposure to oxidative stress 
and inflammation caused by irritants from the air pollution (Autrup, 1999; Lodovici, 2011; 
Moulton, 2012). In line with this, the risks associated with smoking have been reported in 
literature and media for many years. Not only does the tar of cigarettes contain stable free 
radicals which upon inhalation produces O2∙− and H2O2  in the aqueous environment but the 
presence of foreign particles in the alveoli of the lungs and epithelial of the mouth, throat and 
trachea activate an immune response which induces oxidative stress characterised by an 
increase in lipid peroxidation and DNA damage (van der Vaart et al., 2004; Valavanidis et al., 
2009). Coupled with increased free radicals and chronically activated immune responses, 
smoking is also associated with relatively depleted antioxidant systems (e.g. decreased 
antioxidant capacity (TEAC), antioxidant reducing capacity (ARC) and lower GSSG ratio 
(Bloomer, 2007). 
Poor nutrition has also been implicated as a causative factor in chronic disease (Shlisky, 2017). 
In the context of redox, the main concerns are excessive sugar, simple carbohydrates (Hu, 
2006), saturated fats and processed meat products. This is due to the excess chemical 
additives as well as easily destabilised free radicals when these are digested, which have 
several downstream effects (Ma, 2019). Macronutrients in overabundance results in the 
saturation of metabolic processes and can disrupt the growth and maintenance of the gut 
microbiota(Brown, 2012). The resultant environment has an altered pH level, various reactive 
species and damaged molecules which exacerbate oxidative stress.   
2.5.1.2 Endogenous sources 
The endogenous sources, targets of and defensive systems against free radicals differ 
according to their biochemistry, location and function in the intra- and extracellular 
environment (Lü, 2010). Areas within the cell where free radicals are typically produced as 
part of normal metabolism include the mitochondria, peroxisomes, endoplasmic reticulum 
(ER) and nuclear membranes (Lushchak, 2014; Phaniendra, 2015). Free radicals can be 
classified as reactive oxygen species (ROS), nitrosative radicals (RNS) and reactive sulphur 
species (RSS). For the purpose of this thesis, the focus in the next sections will be on ROS/RNS 
only, as their dysregulation is most commonly associated with chronic disease. Although it 
has been suggested that reactive sulphur species should be considered (Giles, 2017), even the 
latest reviews (e.g. Olson, 2020) still seems highly speculative, with not much solid 
information in support of this notion. Given this relative lack of data, a discussion on RSS has 




The majority of reactive oxygen species (ROS) – which make up ≈90% of total free radicals 
present in the body – is generated from the unstable oxygen molecules formed by 
interactions with free electrons from the mitochondrial electron transport chain (ETC)  
(Lushchak, 2014). The ETC is responsible for the generation of ATP, but leaks electrons which 
then interact with surrounding oxygen to form free radicals. The main sites of leakage within 
the ETC are complexes I - the NADH-ubiquinone oxidoreductase - and III - cytochrome bcl 
complex (Zhao, 2019). Escaped electrons are able to enter the intracellular space and interact 
with oxygen within the mitochondria to form superoxide (O2∙−) or hydrogen peroxide (H2O2).  
Of these, H2O2 is more stable and therefore the parameter of choice for assessment of ROS 
levels. 
Other significant inter- and intra- cellular sources of free radicals is the NADPH oxidase 
system, xanthine oxidases (XO) and endothelial nitric oxide synthase (eNOS), the latter of 
which forms part of RNS. NADPH oxidase (Nox), a cytoplasmic membrane enzyme, creates 
free radicals by transferring electrons from NADPH to oxygen (Magnani, 2019). There are two 
subunits which generates superoxide anion (O2∙−) and hydrogen peroxide (H2O2) namely; 
gp91phox, responsible for sequestering of oxygen and p67phox which removes a electron 
from NADPH to NADP+ (Ozcan, 2015). This system of radical generation is particularly 
important within inflammation, specifically as a result of Nox activity on the membranes of 
activated neutrophils. The phagocytic capabilities of these and certain other immune cells 
depend on free radical generation via this pathway. Cytosolic enzymes xanthine oxidases and 
nitric oxide synthase works in a similar manner. Xanthine oxidase is an enzyme which 
functions to break down purine nucleic acids for redistribution and use within a cell. Xanthine 
oxidases, besides being able to generate O2∙− and H2O2 , are the main contributors of uric acid 
formation (Battelli, 2016). Uric acid can exacerbate the intracellular prooxidant environment 
by providing metabolites for the further generation of free radicals. Similarly, nitric oxide 
synthase (NOS) - besides being donors of superoxide and hydrogen peroxide - is a key 
contributor for the production of the oxidant peroxynitrite (ONOO−)(Pole, 2016). NOS 
primarily uses L-arginine and oxygen as substrates and via reduced NADPH creates nitric oxide 
which has multiple functional roles within a cell (Förstermann, 2012). Nitric oxide has a 
multitude of functions in various cell types. In the central nervous system it aids synaptic 
plasticity, whereas in the periphery it functions to regulate blood pressure, smooth muscle 
relaxation and vasodilation (Levine et al., 2012).  
It is important to note though that presence of free radicals are not always undesirable. It is 
important to note that free radicals play an important role in various mechanisms driving 
homeostasis. For example, free radical levels dictate proliferation and/or survival 
mechanisms within cells by activating or inactivating PI3 kinase, MAP kinases, PTEN, and 
protein tyrosine phosphatases, depending on their level present within the cell (Ray et al., 
2012). Large increases in free radical production signals survival by upregulating antioxidant 
capacity whereas lower stable levels indicate a homeostatic state favouring proliferation. It is 




cell death via apoptosis result. (Ray et al., 2012).  These unstable radicals also play an integral 
part in the formation of digestive pathogen destruction capacities in immune cells such as 
neutrophils and macrophages (Kohchi, 2009). For example, bacterial endotoxin such as 
lipopolysaccharide (LPS), as well as pro-inflammatory cytokine (TNF-α) signalling, activate the 
production of ROS as a priming step for phagocytosis (Babior, 2000). These roles highlight the 
importance of sustaining a balance of free radicals within a cell instead of aiming to eradicate 
them altogether. 
Under normal conditions, this balance is maintained by endogenous antioxidant defences. 
Only when these systems are overwhelmed, accelerated ageing will ensue. 
2.5.2 Overwhelmed Antioxidant mechanisms 
Turning attention to antioxidant mechanisms, the human body has many endogenous 
antioxidant defensive systems which under homeostatic conditions quench free radicals at 
approximately the same rate as they are produced. The free radical-activated translocation 
of NRF-2 from the cytoplasm to the nucleus where Kelch-like erythroid cell-derived protein 
with CNC homology-associated protein 1 (KEAP1)(Ma, 2013) to the nucleus, initiates the 
transcription of a number of antioxidant and anti-inflammatory factors, such as superoxide 
dismutase (SOD), glutathione (GSH), glutathione peroxidase (GPx) and peroxiredoxins (PRx) 
(Ray et al., 2012; Chen et al., 2015; Zhang et al., 2015). This finely regulated balance sustains 
a cellular environment which favours survival and optimal function of the cell. Most relevant 
to the topic of accelerated ageing, NRF2 signalling has been shown to be decreased in 
advanced age (Sykiotis, 2013). It has been speculated that this is mainly due to modification 
of NRF2 and Keap1 signalling. A similar trend was reported in diseases and genetic 
abnormalities (Zhang et al., 2016; Tu et al., 2019). Signalling of these two factors changes due 
to cumulative stress or damage to DNA and post-translational machinery. (Sykiotis, 2013). 
The subsequent decrease in NRF2 signalling results in decreased antioxidant capacity, which 
leaves cells vulnerable to oxidative damage (discussed in more detail in section 2.5).  The 
endogenous antioxidant systems downstream of NRF2 are adaptive to an extent and can be 
up or down regulated to cater to smaller increases or decreases in free radical production 
(Valko, 2007) to maintain homeostatic balance. There are various sites and types of 
antioxidant systems which target different free radicals based on location and type, to either 
quench free radicals, limit their production, or protect their targets against oxidative damage.  
2.5.2.1 Enzymatic antioxidants 
Enzymatic antioxidant defences include most prominently superoxide dismutase (SOD), 
glutathione peroxidase (GSHPx) and catalase (CAT), and peroxiredoxins (Prx–I). These 
antioxidant systems are present in the cytosol, mitochondria and peroxisomes, closest to the 
sources of free radicals. The main mechanism of action of this group of antioxidants is to 
catalyse the reduction of free radicals such as O2·- and H2O2 into stable molecules such as H2O, 
O2, GSSG, Trx(SH)2 and H2O2 (Rahal, 2014).  Depending on the location of these antioxidants, 




to stabilise free radicals by donating ions (Nimse and Pal, 2015). Some of these enzymes are 
able to work in synergy to increase antioxidant capacity, especially during cellular stress. An 
example would be the interaction of the predominate enzymes SOD, CAT and GSHPx 
(Lushchak, 2014).   
2.5.2.2 Non-enzymatic antioxidants 
Non-enzymatic antioxidants such as ascorbic acid, α-tocopherol, glutathione (GSH), 
carotenoids and flavonoids supplement the predominating enzymatic antioxidant 
mechanisms(Powers, 2004). In this context in particular, preventative supplementation has 
become a focus, as many of these antioxidants may also be derived from food or plant 
extracts. Non-enzymatic antioxidants can be further divided into lipid soluble (vitamin A, α-
tocopherol and carotenoids) and water soluble (ascorbic acid, vitamin B6 and flavonoids) 
compounds and these properties dictate their location and mechanism of action(Lobo, 2010). 
Lipid soluble antioxidants are able to scavenge and disrupt peroxidation of lipids to prevent 
damage to cellular structures. Although under relatively stable conditions these molecules 
result in stable products under certain conditions of stress and excess ·OH they can result in 
unstable by-products which are reactive and add to the free radical burden.  
Water soluble antioxidants, especially flavonoids which are predominately found in fruits and 
vegetables, function by donating electrons to free radicals and thereby stabilizing volatile 
molecules (Rietjens, 2002). Bioflavonoids include a variety of subcategories of antioxidants 
such as quercetin, taxifolin, catechin, anthocyanidin and daidzein to mention a few. Their 
structures determine their main mechanism of action, but their common function remains 
the quenching of radicals (Kandaswami, 1994). Due to the diversity of structures they are able 
to exert protective mechanisms on lipids, DNA and proteins depending on the number and 
location of phenolic rings and number of electrons available for donation, this includes the 
ability to chelate metal ions (Kandaswami, 1994). 
Also, in this context, the modern lifestyle seems to have detrimental effects. In addition to 
the direct upregulation of free radicals due to poor diet, as already mentioned, the lower 
nutrient content of mass-produced food has resulted in a decrease in antioxidant intake by 
the general population (Hu, 2006; Cardoso, 2010). A relative lack of various  antioxidants and 
components required to stimulate endogenous production of antioxidant systems was 
reported in mass-produced fresh produce (Wang, 2008; Fernandes, 2012). The result is 
decreased dietary intake of necessary macronutrients and antioxidants, decreasing both 
exogenous and stimulated endogenous antioxidant capacity. 
Another significant role player contributing to the imbalance between free radical production 
and antioxidant counter mechanism activity, is persistent chronic low-grade inflammation, 
which is a widely accepted characteristic of modern chronic disease(Gill et al., 2010; Reuter 





2.5.3 Low grade inflammation as confounding factor 
While normal activation of neutrophil-associated ROS production via the NADPH oxidase 
pathway is desirable, persistent activation of inflammation – the so-called low-grade chronic 
inflammation – contributes significantly to accelerated ageing by dysregulation of the redox 
system. 
The link between oxidative stress and inflammation is perhaps best demonstrated by using as 
example, the formation of neutrophil extracellular traps (NETS). The abilities of neutrophils 
range from antigen sensing to phagocytosis, and these cells are equipped with machinery 
which unchecked can cause a vast amount of secondary damage. NETS are complexes 
composed of DNA, histones, and granule proteins which form fibres designed to trap 
pathogens (Yang, 2016). Neutrophils create NETs when ligands bind to cell surface receptors 
and activate a cascade of events which are designed to use ROS production to digest the 
entrapped particles (Vorobjeva, 2014). There are varying degrees of NET formation which can 
either lead to the death of the neutrophil or structural changes, but both of these events use 
can lead to ROS increases (Driouich, 2019). Neutrophils use mainly NADPH, NOX and MPO to  
generate ROS after the influx of calcium in activated by the signalling of receptor binding 
(Papayannopoulos, 2018).   
In the innate immune system unchecked or inefficient immune responses can cause severe 
secondary damage which perpetuates the inflammatory response and prolong it. Cells of the 
innate immune system can mount aggressive responses once activated and in doing so create 
a considerable amount of damage.  Interestingly, the link between NET formation and ROS 
appears to be bidirectional: superoxide is also known to recruit neutrophils to sites of 
pathogenic inflammation, and recently it has been shown that superoxide is able to activate 
the neutrophil extracellular trap formation by activating the signalling cascade of Toll-like 
receptors (TLR-4) as well as NADPH oxidase (NOX) (Al-khafaji, 2016). 
Furthermore, physical activity, both excessive exercise and lack thereof, has been identified 
as a promotor of inflammation and oxidative stress, and ultimately chronic disease.  The 
sedentary lifestyle is characterised by lack of exercise, low muscle mass and decreased 
cardiovascular capacity (González, 2017). Lower muscle mass translates to decreased capacity 
to utilise glucose, especially when supplied in excess through dietary intake. This is due to 
fewer contractile muscle cells which utilise glucose as their main energy source (Davies, 
2018). Besides decreased glucose uptake, lower muscle mass decreases insulin signalling, 
growth hormones and antioxidant capacity of surrounding tissue (Thyfault, 2020). This, 
combined with increased adipose deposition, is a predictor of chronic disease such as 
diabetes and insulin resistance (Hwang, 2016). In contrast, habitual mild exercise has been 
shown to increase antioxidant capacity and has anti-inflammatory properties (Wadley, 2016), 
even at low intensities and frequencies (Rabelo, 2017). Exercise has been prescribed to 
patients suffering with cardiovascular, metabolic and psychological diseases due to the 




(Luan, 2019). Unfortunately, the lack thereof in the daily routine, low adherence to exercise 
programs and lack of resources have made physical activity low priority to many in urbanized 
areas.  
Finally, besides the dysfunction of the immune cells, organs and systems themselves, 
persistent low-grade inflammation has secondary effects on other organ systems. One such 
tissue is the adipose tissue, which is relatively well researched only in the context of diabetes 
and metabolic disease (Minamino, 2009; Ricordi, 2015; Nosalski, 2017), while data in the 
context of  ageing is relatively lacking, especially when considering adipose tissue as a 
potential ageing accelerating tissue type.  Adipose tissue is easily infiltrated by macrophages, 
T cells, regulatory cells, natural killer and granulocytes (Ahima, 2009), which results in a pro-
inflammatory environment within the tissue specifically in obesity (Fernández-Sánchez, 
2011). Coupled with the fact that adipocytes themselves produce high levels of ROS 
(Tchkonia, 2010; Engin, 2017), this tissue can become vulnerable to DNA damage due to 
relatively low levels of antioxidant defences (Fernández-Sánchez, 2011), again propagating 
the inflammatory damage-repair cycle. This condition is perpetuated by aged adipocytes via 
their increased production and secretion of pro-inflammatory cytokines (Tchkonia, 2010). 
2.5.4 Oxidative damage 
Excessive availability of free radicals alters the molecular make up and thereby damages cell 
constituents crucial for homeostatic functioning within the cell and in the surrounding cellular 
microenvironment. The extra-cellular environment is particularly vulnerable to leakage of 
damaged molecules and free radicals into the extracellular space, resulting in a stress signal 
to surrounding cells because there are no quenching mechanisms (Valko, 2007). Unstable 
molecules are thus able to act on circulating factors which has multiple downstream effects.     
In terms of cellular oxidative damage, membrane lipids, cellular proteins and DNA are main 
targets affected by free radicals. The superoxide anion and the hydroxy radical are primarily 
responsible for damage to lipids, and in particular membrane lipids. The membranes affected 
are not only cellular membranes, but also organelle membranes within the cell, such as 
mitochondria (Miquel, 1980). Damaged membranes lead to exacerbated leakage of 
incomplete proteins, electrons and reactive molecules from cells (Avery, 2011).  
Furthermore, DNA oxidation is initiated by hydroxy radicals and singlet oxygen, by exposing 
sections of DNA to iron (Fe) catalysation and ultimately chromosomal rearrangements. Any 
damage done to DNA is normally repaired as a result of  repair mechanisms in place, such as 
Poly-ADP ribose polymerase 1 (PARP-1) (Houben, 2008). The combination of repair systems 
and telomeres at the ends of DNA work to protect DNA from damage, but their capacity is 
not unlimited,  (Hayflick, 1965). This translates to a limited ability for cells to repair themselves 
after being damaged repeatedly. Telomeres are DNA repeats present at the both ends of 
chromosomes. Telomeres have a set length of kilobases per chromosome and these excess 




Once the capacity of cells’ innate repair systems such as telomeres or PARP-1 are depleted, 
the cell begins to senesce which causes downstream maladaptations.   
Similarly, protein damage occurs when residues are exposed to oxygen radicals. This process 
is catalysed by Cu(II) or Fe(III), and results in the exposure of amino acids the ·OH which is 
formed in prior reactions with oxygen radicals (Cecarini, 2007). The free radical damage to 
proteins causes the dysregulation of signalling molecules which effects a plethora of intra-
and intercellular cascades (Hawkins, 2019). 
The combination of consistent damage repair cycles and overrun antioxidant mechanisms 
eventually lead to a state of maladaptation which when prolonged results in irreversible 
damage and disease. This is essentially how cumulative oxidative stress is postulated to lead 
to accelerated ageing.  
2.6 Prevention of accelerated ageing   
Over the past decade, a huge body of evidence has been established which suggests the 
benefit of preventative antioxidant supplementation in the context of accelerated ageing-
associated chronic conditions, albeit not without limitations. Several animal models are used 
to study specific conditions. However, to my knowledge, no rodent model suitable for 
accurate simulation of pre-pathology events – i.e. before onset of accelerated ageing - has 
been described to date. There are a number of knockout models used to investigate 
mechanistic role players of the process of ageing such as Nuclear Factor Kappa B Subunit 1 
(Nfkb1)−/− mice or Telomerase RNA Component (Terc)−/− mice (Kõks, 2016; Folgueras, 2018) 
but these are not a suitable simulation of gradual maladaptation pre-onset of accelerated 
ageing and its related pathologies. The maladaptations onset is immediate, and intervention 
is not possible.  
There are animal models which demonstrate accelerated ageing diseases but are long in 
duration and induce severe pathologies which does not allow researchers to assess the 
threshold at which maladaptation becomes irreversible pathology (Yanar, 2011; Azman, 
2019).      
To design a suitably mild model for investigating delayed accelerated ageing, it is necessary 
to first understand the methodology used and parameters most commonly assessed in 
research related to decelerated ageing.  
2.6.1 Assessing redox status 
Redox status is most frequently assessed using a variety of tests which either measure the 
number of free radicals, the capacity of the antioxidant mechanisms to quench radicals, or 
the extent of cellular damage.  
 A number of assays are set up to measure the number of free radicals within a sample. One 
such assay is the 5-(and -6)-carboxy-2′,7′-dichlorodihydrofluorescein diacetate (DCFDA) assay, 




detect levels of H2O2, in a sample. This probe is able to diffuse into cells and reacts with 
esterases within the cell to form the hydrolyzed DCFH. H2O2 reacts with DCFH and results in 
the formation of 2′,7′-dichlorofluorescein (DCF) which fluoresces at an excitation of 488 nm 
and emission of 530 nm. The intensity of the fluorescence is therefore indicative of the 
amount of H2O2 in the cell. In a similar mechanism, O2- reacts with dihydroethidium (DHE) to 
fluoresce red at an excitation of 488 nm and an emission of 585 nm. There are various probes 
used to target radicals in this way, and this has become the method of choice to quantify the 
radical load within cells or aqueous samples (Katerji, 2019). 
Assays designed to test the antioxidant functional capacity of a sample are mainly based on 
the principle of introducing a standardised amount of free radicals and measuring the ability 
of the antioxidants within the sample to quench the new labelled radicals. Examples of these 
are ORAC (oxygen radical absorbance capacity), TEAC (Trolox equivalent antioxidant capacity) 
or FRAP (Ferric-reducing ability of plasma).  The ORAC assay determines the loss of 
fluorescence based on the antioxidant ability of a sample to prevent the oxidation of the 
probe compared to a blank/control (Katerji, 2019). It does not give a clear indication of the 
specific antioxidant mechanisms involved but rather a total measure. The TEAC assay works 
on a similar principle, where the loss of colour is indicative of antioxidant power. TEAC makes 
use of the 2,2’-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid)(ABTS) oxidation to detect 
total antioxidant capabilities(Somogyi, 2007). FRAP measures the ability of a sample to reduce 
the ferrous–tripyridyltriazine complex indicated by a colour change (Benzie, 1996).  
There are also assays assessing the level of specific endogenous antioxidant molecules such 
as SOD, CAT and the GSSG:GSH ratio (Katerji, 2019). Most of these methods are based on the 
ability of the antioxidant to inhibit the autoxidation of a colour changing or fluorescent probe 
or complex. The GSSG:GSH ratio is calculated from an assay which measures the amount of 
reduced GSH in comparison to oxidized GSH (GSSG). The ratio is an indicator of cellular health, 
as GSH is the most abundant antioxidant system within cells (Stevens, 2010).  
Lastly, a number of tests are available to measure the amount of cellular damage, in three 
main categories, namely DNA, protein and lipid damage.  Protein damage is evaluated by 
measurement of altered carbonyl groups on proteins. There are three types of damage 
proteins may incur; oxidation of specific amino acids, peptide cleavage due to free radical 
exposure and protein cross-linkage as a result of a reaction with lipid peroxidation products 
(Lobo, 2010).  
Damaged lipids can be detected at various stages of oxidation: conjugated dienes are early 
markers of lipid damage whereas the TBARS (Thiobarbituric) assay measures late marker MDA 
(Malondialdehyde) (Lushchak, 2016). Conjugated dienes are the result of peroxyl free radicals 
adding to the carbon-carbon bonds of lipids. These complexes may be salvaged before further 
oxidation into MDA (Pisoschi, 2015). Metabolites at various stages of lipid peroxidation which 
are also measured include 8-iso- prostaglandin F2α (8-iso-PGF2α), 4-hydroxy-2-nonenal (4-




ultra-high-performance liquid chromatography-tandem mass spectrometry whereas 4-HNE 
can be detected using immunohistochemistry or HPLC. CD’s and MDA can both be detected 
using spectrophotometry using reasonably simple repeatable methods and equipment.  
Then there are assays designed to measured DNA damage, namely 8-oxo-7,8-dihydroguanine 
(Collins, 2005) which detect the hydroxylation of the deoxyguanosine residues. This is mainly 
done using HPLC coupled with an electrochemical detector (ECD) (Katerji, 2019).      
In order to form a holistic picture of redox status, assessments of redox parameters ideally 
should cover various steps within the cascade of free radical formation and antioxidant 
capacity increase signalling. Most commonly protein damage is reported in the literature 
because it is frequently detectable, and a stable metabolite of oxidative damage in various 
tissues and compartments. It is a good indication of the state of the oxidative balance at the 
specified time point but may not be the most sensitive parameter to measure to identify the 
threshold prior to maladaptation. Antioxidant capacity as measured by FRAP has shown to 
fluctuate according to the stressors placed on the system and may be a better early indication 
of changes to redox status. The antioxidant capacity upregulates when increased free radicals 
are sensed, but once damage has overrun compensatory mechanisms a decreased in FRAP 
has been reported, the sensitivity of this parameter may be a better indication of a shift 
towards maladaptation prior to pathology.   
Preventative medicine aims to identify targets prior to such drastic shifts in cellular 
homeostasis.  The majority of preventative antioxidant medicines investigated to date, are 
phytomedicines. In the next section, I provide an overview of relevant literature to 
demonstrate the mechanisms most commonly assessed and elucidated in this context. 
2.7. Antioxidant phytomedicines 
From pre-clinical studies, there are multiple examples of preventative strategies which have 
proven effective in reducing oxidative stress – many of these phyto-extracts (Zittermann, 
2003), grape derived polyphenols (Xiao-bin, 2011; Petersen, 2016), strawberries (Bialasiewicz, 
2013),  blueberries (Wu, 2018) and other herbal treatments (Stough, 2012). Plant-derived 
antioxidants may thus pose a compelling strategy to limit both oxidative stress and 
inflammation.  
Several detailed reviews have been published on anti-inflammatory and/or antioxidant 
effects of various phytomedicines. In Table 2.2, I merely provide a representative summary 
to illustrate the wide variety of chronic conditions, as modelled in animal models, showing 





Table 2.2. Representative summary demonstrating various animal models which mimic chronic disease or accelerated ageing, and which have reported 
benefits of phytomedicine interventions in the context of redox and/or inflammatory profile
Study model Treatment Antioxidant effects 
reported 
Anti-inflammatory effects Reference 
Murine model of Crohn’s 
disease 
ellagic acid (EA)- enriched 
pomegranate extract 
 ↓ MPO and TNF-α levels  (Rosillo, 2012) 
Senescence-accelerated 
male mice 
Resveratrol ↑SOD activity, 
glutathione peroxidase 
reaction restored to 
normal, ↓ MDA 
 (Liu, 2012) 
Collagen-II Induced Arthritis 
(CIA) Rat Model 
Eucommia ulmoides Oliv.  ↓ RNA levels of IL-6 and 
IL-17  
(Zhang, 2008) 









↑phagocytic ability, ↑ 




(DMBA) induced mammary 
carcinogenesis in female 
Sprague Dawley rats 







Alzheimer’s Model in Rats 
Phyllanthus reticulatus 
(PR) Poir. 
↑SOD and CAT, ↓ MDA, 
↓AChE activity 
 (Uddin, 2016) 
Non-alcoholic Fatty Liver 
Disease Induced by High-fat 
Diet in Mice 








From this, clearly there is a place for phytomedicines in disease prevention.  
Despite the small number of human studies available, data reported from clinical studies 
indeed support a role for antioxidants in the preventative medicine niche. For example, in a 
study conducted in elderly women who acutely consumed antioxidant-rich foods such as red 
wine, strawberries, vitamin C or spinach, marked increases in serum antioxidant capacity 
were reported four to 24 hours post-consumption, as reflected by increased Trolox equivalent 
antioxidant capacity (TEAC), oxygen radical absorbance capacity (ORAC) and ferric reducing 
ability (FRAP) (Cao, 1998). Also in a more chronic study design, benefits have been reported.  
For example, rooibos tea (an aqueous extract of Aspalathus linearis) was also shown to have 
preventative potential in humans at risk for coronary heart disease (Schloms, 2014). In a study 
by (Macharia, 2008) volunteers exhibited increased plasma total polyphenol content after 
consumption of six cups of tea daily for a six-week period. Importantly there were significant 
decreases in markers of oxidative damage (conjugated dienes and malondialdehyde). This 
study demonstrated the potential of a plant derived antioxidant to decrease systemic markers 
of oxidative stress in at risk populations, but in the absence of clinical pathology. 
Resveratrol has shown positive antioxidant modulatory capacity in multiple studies. In a study 
by Seyyedebrahimi and colleagues (2018), diabetic patients showed increased antioxidant 
capacity after a two-month supplementation period, combined with decreased levels of 
detectable damage and free radicals.  The most interesting finding was the increased 
expression of Nrf2 encoding for various genes with products involved in antioxidant 
mechanisms (Seyyedebrahimi, 2018). Various studies, such as this have been reviewed by 
Singh et al. (2019) and consistently show antioxidant and anti-inflammatory modulation 
within various disease states (Singh, 2019). One of the most important findings is the 
upregulation of sirtuin following intake of resveratrol supplementation This protein is not only 
responsible for regulating antioxidant mechanisms but is also implicated in cellular 
senescence and ageing (McHugh, 2018; Singh, 2019). Sirtuin activation by the polyphenol 
resveratrol can mimic lifespan extending effects and alleviate metabolic diseases.  
A significant gap in the literature in the context of prevention of accelerated ageing and 
associated chronic disease, is that very few studies assess and report on both oxidative and 
inflammatory status in the same study, while even fewer evaluate outcome in various tissue 
compartments in addition to circulatory measures. Also, for the purpose of elucidating the 
threshold at which endogenous counter mechanisms are exhausted and accelerated ageing 
ensues, clearly milder models and earlier time points should be assessed. 
2.7.1 Grape-seed derived antioxidants 
Of particular relevance to this thesis topic, a specific group of polyphenols derived from 
grapes has aroused much interest in the natural antioxidant and anti-inflammatory research 
niches. Grape derived polyphenols contain a variety of bioactive flavonoids which account for 




contain mainly catechin, epicatechin, anthocyanidins and/or proanthocyanidins (Fernandes, 
2016). The -OH groups of the phenolic rings of anthocyanidins are responsible for their ability 
to quench free radicals, as well as inhibiting oxidation of lipids by donating electrons and 
chelating unstable metal ions (Nimse, 2015a). Catechin and epicatechin work in a similar 
manner but require subsequent reactions to form stable products once -OH groups have been 
metabolised (Nimse, 2015b). Grape polyphenols’ anti-inflammatory abilities stem from their 
ability to reduce ROS levels and thereby inhibit NADPH oxidase activation and NF-κB 
signalling, which are sensitive to increasing ROS level (Fernandes, 2016). Grape polyphenols 
have strong anti-inflammatory properties due to their additional metal chelating properties, 
removing copper and iron, which in inflammation are important signalling molecules in the 
inflammatory cascade (Nimse and Pal, 2015).  
2.8 Potential risks involved in antioxidant supplementation 
In terms of consumer safety, it is important to consider that – depending on the existing host 
redox status and of course antioxidant dose employed – antioxidants may have potent 
physiological effects. Thus, in order to prevent undesired effects or toxicity, especially when 
compounding different supplements, a clear understanding of the mechanism(s) being 
targeted by preventative strategies is vital, especially in the context of plant-based 
antioxidants because of the synergistic effects different active ingredients in plant-derived 
antioxidants may have (Li, 2016).  
The risk for antioxidant toxicity has been illustrated in the literature (Rietjens, 2002). An 
example is ROS-induced MAPK signalling pathways, which can affect differentiation, growth 
and inflammatory signalling within a cell under normal homeostatic conditions. Under 
conditions of higher oxidative stress, antioxidant mechanisms are used to attenuate excessive 
free radicals before they affect signalling and the downstream biological functioning 
(Bhooshan Pandey, 2009). Upon adding an exogenous antioxidant or antioxidant stimulant, 
to the extent where free radicals are eradicated and the antioxidant itself becomes pro-
oxidant, the beneficial effects of such supplement is outweighed by its cytotoxicity. 
Oversupply of small molecule antioxidants exhaust endogenous “stabilisers”, so that unstable 
intermediaries are formed, which exert free radical-like damage themselves. A significant 
concern in the context of antioxidant supplementation is mega-dosing. Mega-dosing and 
compounding antioxidants can have toxic effects, and this is an issue which needs to be 
addressed because antioxidants are freely available to laypersons. Mega-dosing is the intake 
of larger than recommended dosages of a or multiple supplements with the intention of 
increasing the beneficial effects. Research is required to safely compound antioxidants or 
administer mega doses because as described above oversupply, especially in the absence of 
severe pathology, may lead to cytotoxicity (Powers, 2004; Cásedas, 2018).   
2.9 Summary 
In summary, the phenomenon of accelerated ageing clearly results from a plethora of 
different role players. An original visual summary of the interactions between free radical 




preventative phytomedicines, is presented in Figure 2.1.  I have pointed out several gaps in 
our understanding of role players in accelerated ageing – the first being a lack of specific 
models with which we investigate the progression of accelerated ageing especially the 
threshold prior to the onset of irreversible pathology. This is imperative to identify potential 
parameters which we monitor to assess the progression of accelerated ageing and age-
related pathologies as well as risk populations. This is important because it also allows 
researchers to identify possible therapeutic targets which may decelerate or attenuate the 
maladaptations which take place and lead to pathologies may give insight in not only 
treatment options but also preventative targets. Secondly the need to elucidate sensitive 
parameters which reflect small effect size changes before maladaptation takes place and 
shifts the homeostatic status quo. Considering the complex interplay between effectors of 
both oxidative stress and inflammation, it is clear that one cannot solely assess either one 
without the other. The gap in the literature is mainly in the identification of which combined 
parameters should be assessed prior to severe pathology and which could be targeted in the 
preventative medicine niche. It is also apparent that assessing a single compartment is 
insufficient as damage or maladaptation in one compartment may relate to a compensatory 
mechanism in another. Cross-sectional and comprehensive assessments are necessary to 
elucidate the whole-body status and this approach may be the key in identifying holistic 
treatment options.    
Plant-derived antioxidants may significantly contribute to delaying this abnormal ageing 




 Figure 2.1: Various sites of free radical production and the main targets of different antioxidant 
defences, including sites of intervention by plant derived antioxidant treatments. Note: SOD- 
Superoxide dismutase, CAT- catalase, OONO·- peroxynitrite, Prx-1- peroxiredoxin-1, GSHPx- 
Glutathione Peroxidase, Cu- copper, Zn- zinc, Mn- manganese, NO- Nitric oxide, vit C/A- vitamin C/A, 
H2O2-hydrogen peroxide, OHˑ-hydroxyl radical, H2O- water, O2 -oxygen, O2ˑ- - superoxide anion   
Considering the vast array of potential antioxidant and anti-inflammatory plant derived 
supplements, especially grape derived, a strategy which has modulatory potential but to a 
milder extent has the ability to enhance the preventative medicine niche.    
This review has shown that a dysregulation of redox status results in oxidative damage, which 
causes inflammation and ultimately accelerated ageing. This phenomenon of accelerated 
ageing is valid for many different conditions, which are often associated with advancing age. 
Throughout this review it has also been highlighted that that suitable models for screening of 
preventative medicine within pre-pathology and specific disease contexts, are very scarce. 
The need is to identify the point at which adaptation becomes maladaptation, so that one is 
able to test the ability of supplements to prevent or delay a switch to pre-pathology. 
Enhancing the knowledge in this field is essential in order to responsibly prescribe antioxidant 
treatment in the preventative medicine niche, it is necessary to evaluate both redox pathways 
and inflammation comprehensively, as this is the only way in which therapeutic targets may 
be identified and effects (and side-effects) of supplements fully elucidated to begin targeting 





2.10 Hypothesis and aims 
I hypothesised that it is possible to simulate pre-pathology accelerated ageing in rats, using 
either an oxidative stress insult or a trigger of chronic inflammation as primary stimulus.  
Furthermore, I hypothesised that these models will be sufficiently sensitive to reflect benefits 
of antioxidant supplementation in the context of accelerated ageing. 
In order to test these hypotheses, I aimed to simultaneously assess various redox and 
inflammatory parameters across various tissue compartments in both an inflammatory and a 
pro-oxidant model of accelerated aging in rats, in order to identify the most suitable 
therapeutic targets with which to assess potential efficacy of antioxidant preventative 
supplementation.  
Specific objectives were formulated as follows: 
 To modify a known model of D-galactose-induced neurodegeneration to simulate a 
pre-pathological state mimicking early stage accelerated ageing-associated 
maladaptation. 
 To characterise the oxidative and inflammatory status in the D-galactose model in 
various compartments by assessing multiple tissue types for both oxidative and 
inflammatory parameters, as well as potential effects of a well-researched antioxidant 
 To establish a model of accelerated ageing using induced rheumatoid arthritis in 
rodents to characterise the oxidative and inflammatory status in this immune 
response. 
 To characterise the oxidative and inflammatory status in the induced rheumatoid 
arthritis in various compartments by assessing multiple tissue types for both oxidative 










D-galactose model of oxidative stress-induced accelerated ageing in rats 
A truncated version of this chapter has been published in Biogerontology (impact factor 
3.667).  
Citation reference: Ross KS, Smith C. D-galactose: a model of accelerated ageing sufficiently 
sensitive to reflect preventative efficacy of an antioxidant treatment. Biogerontology. 2020 
Jul. DOI: 10.1007/s10522-020-09891-x. 
3.1 Abstract 
Considering that the phenomenon of accelerated ageing contributes to early onset of various 
chronic diseases, modelling of the relevant dysregulated systems or responses is vital for 
research aimed at identification of potential therapeutic targets. Here, we aimed to establish 
a model capable of simulating the redox and inflammatory changes of accelerated ageing – 
specifically, the aim was early phase accelerated ageing, which would allow therapeutic 
intervention in a preventative approach prior to clinical disease manifestation. A secondary 
aim was to evaluate the sensitivity of the model to reflect preventative treatment efficacy.  
Daily D-galactose injections (250 mg/kg body mass/day) for 8 weeks in 9-week-old male 
Wistar rats induced a model of early accelerated ageing (decreased plasma FRAP; P<0.05 and 
altered inflammatory signalling) and an aged profile in lymph node ultrastructure, but did not 
yet result in telomere shortening.  Preventative daily oral antioxidant administration (grape 
seed-derived polyphenol, 100 mg/kg body mass) prevented tissue ageing, beneficially 
modulated the inflammatory response, including neutrophil chemokinetic capacity, and 
tended to increase absolute telomere length.  
Data suggests that using a mild model of D-galactose administration than those employed to 
induce neurodegeneration, simulated the point where oxidative stress starts to overwhelm 
the endogenous antioxidant response and where a pro-inflammatory phenotype switch 
manifests. Furthermore, despite the expected small effect size, the model was sufficiently 
sensitive to reflect benefits of preventative antioxidant treatment in the context of ageing. 
This model presents a practical model for use in drug discovery, particularly in the context of 
preventative medicine aimed at limiting oxidative stress-associated ageing. Since this starting 
point of accelerated ageing as illustrated by current data, is not expected to reflect major 
ageing-associated changes yet, we recommend that future preventative drug discovery 
studies employ a longitudinal study design in order to clearly demonstrate the delay of this 
starting point by preventative strategies.  
3.2 Introduction  
The concept of ageing is complex and insufficiently understood. There are many theories as 
to the causes of ageing; these range from the Free Radical theory of ageing (Harman, 2002) 
and the mitochondrial theory of ageing (Miquel, 1980) to the Replicative Senescence theory 
of ageing (Hayflick, 1965; Saretzki, 2002), as described in the literature review chapter. Each 




possible treatments to “slow down” or prevent the ageing process. The one commonality 
across all theories however is the role of oxidative stress in the promotion of ageing.    
Accelerated ageing is the presentation of a senescent phenotype at an earlier than expected 
chronological age and results from cumulative maladaptation and eventually pathologies 
which are characterised by oxidative stress  and chronic inflammation (López-otín, 2013; von 
Kobbe, 2018). The current theories of accelerated ageing attributes this phenomenon to 
many factors induced by the modern lifestyle, such as increasing psychological stress, 
sedentary lifestyle, poor diet and exposure to environmental pollution (Benayoun, 2015; Pole, 
2016; Ventura, 2017). Essentially these factors increase the exposure of the body to cellular 
oxidative damage and low-grade inflammation. Persistent activation of the immune system 
and imbalance of the redox state results in an increase of the allostatic load (Juster, 2010). 
The increased load leads to maladaptation of the systems normally in place to maintain 
homeostasis. Ultimately these persistent perturbations result in pathology which offsets 
disease and negative symptoms, clinical manifestations which normally are noted with aged 
populations. Although viewed as two separate mechanisms, oxidative stress and 
inflammation are linked by many signalling molecules and pathways. Propagation of either of 
these mechanisms can result in exacerbation and/or activation of the other (Reuter, 2010; 
Fernández-Sánchez, 2011).  Thus, once started, this self-enforcing circle of oxidative damage 
and inflammation is hard to resolve. 
Research into ameliorating accelerated ageing has now become a niche area, where the aim 
is to prevent disease onset and to address maladaptations which may ultimately lead to 
chronic disease and mortality (Petersen, 2016). Preventative medicine has recently gained 
momentum due to the growing burden that chronic non-communicable disease are placing 
on health care systems globally (Bauer, 2014), with relatively younger populations being 
diagnosed with conditions normally associated with advancing age (Reddy, 2005; Smith, 2009; 
Bauer, 2014). 
In order to effectively identify therapeutic targets for preventative strategies, efficient models 
of accelerated ageing are required that would allow high throughput screening to investigate 
treatment options. One of the main challenges of studying the progression of ageing is 
developing suitable models that approach ageing-related research from a systems 
perspective (i.e. in vivo) but at the same time allow for targeted, in depth tissue analysis. 
Many models currently in use were designed to mimic specific age-related diseases at mid- 
to late stage and is therefore not appropriately to simulate the relatively gradual changes 
which occur over time with natural ageing, but which can lead to the onset of pathology once 
sufficiently cumulative (Ho, et al. 2003). This means that maladaptive changes occurring prior 
to clinical disease onset - which can be addressed with preventative treatments – cannot be 
accurately simulated. This limitation is a significant obstacle in the progress of drug discovery 




We have identified one model with potential to fill this gap in the preventative medicine 
research methodology. Originally intended (and still used) to simulate Alzheimer’s disease-
associated neurodegeneration (Ho, 2003; Shwe, 2018), this model warrants further 
assessment in the context of ageing, as it could address the logistical challenges which usually 
presents in ageing research models. The rationale behind the original design of the model was 
to induce excessive cumulative oxidative stress by daily subcutaneous injections of a high 
dose D-galactose solution. The excessive oxidative stress in the periphery would then induce 
oxidative stress centrally and offset neurodegeneration over an 8-10-week period.  
Most relevant to the consideration of whether the model could be adapted as model for pre-
pathology accelerated ageing, Alzheimer’s disease is known to present with excessive free 
radical presence, oxidative damage and (at late stage) also decreased antioxidant capacity 
and protein aggregation (Valko, 2007; Uttara, 2009) centrally. While it is postulated that 
oxidative damage is an early hallmark of neurodegeneration,  it is also associated with 
activating an inflammatory response which is more pronounced in mid to late stage disease 
(Calabrese, 2007; Moulton, 2012). Given these similarities between the model, natural ageing 
and the accelerated ageing profile reported in chronic diseases with an inflammatory 
component, we aimed to adapt and expand the use of the D-galactose model to a more 
general model of accelerated ageing, by characterising its systemic outcome in terms of 
ageing-related parameters associated with inflammation and/or oxidative stress.   
A second aim was to assess the sensitivity of this model to reflect preventative efficacy of a 
grape-derived polyphenol antioxidant with demonstrated antioxidant and anti-inflammatory 
effect. (Bagchi et al., 2000; Kruger and Smith, 2012; Myburgh et al., 2012; Kruger et al., 2014; 
Petersen et al., 2018; Oyenihi et al., 2019). Of particular reference to our topic of accelerated 
ageing, the ability to modulate oxidative stress and low-grade inflammation may present a 
broadly applicable preventative strategy for age-related disease and a novel application of 
this grape-derived polyphenol. Previous work done by myself demonstrated the potential of 
this grape-derived polyphenol to attenuate age-related detriments in the context of 
inflammation (Petersen et al., 2018). This study showed how neutrophils isolated from aged 
human donors, which displayed inefficient activation and chemotactic mobility, could be 
corrected to a more efficient “younger” phenotype after acute administration of the grape-
derived polyphenol in vitro. Furthermore, a human clinical trial demonstrated molecular 
targets on neutrophils which may explain the more efficient movement achieved after 
polyphenol administration (Smith et al, 2018). An unavoidable limitation – given the normal 
phases in clinical trial methodology – of this first human study was that the study population 
was normally healthy, young individuals. Thus, given the expected small effect size possible 
in this relatively uncompromised population, in combination with the expected significant 
inter-individual variation, comprehensive redox analysis was not performed. Thus, an in vivo 
model of standardised experimental accelerated ageing may present a more feasible model 




“starting point” of accelerated ageing induced by D-galactose, by assessment of redox and 
inflammatory status in a variety of tissues. 
3.3 Materials and Methods  
3.3.1 Experimental animals and ethical considerations 
All experimental procedures were conducted in accordance with ethical guidelines set out by 
the South African MRC. All protocols were ethically cleared by the Animal Research Ethics 
Committee of Stellenbosch University (ref#0146)(Appendix A).  
Forty male Wistar rats were obtained from the Stellenbosch University Animal Facility at 6 
weeks old (average body mass, 200 ± 46.66 gram). Rats were subjected to a 12:12 light-dark 
cycle (lights on at 6am) and housed in groups of 5 rats per cage in a temperature- and 
humidity-controlled room (23 ± 1°C, 40–60% humidity). Animals consumed standard rat chow 
and tap water ad libitum. Rats were matched according to body mass and divided into 4 
groups; a normally ageing placebo group (NP, which received a placebo of the oral treatment), 
a normally ageing grape seed-derived proanthocyanidin treated group (NG, which received 
daily GSP treatment), a D-galactose-induced ageing group (AP, which received daily D-
galactose injections only) and a group which received daily D-galactose injections and GSP 







Figure 3.1: Visual presentation of experimental layout to induce accelerated ageing via daily 
injections of D-galactose. 
A model of D-galactose-induced ageing was executed in 9-week-old male Wistar rats by daily 
subcutaneous injections of D-galactose (G0750-50G, Sigma) dissolved in saline at 250 mg /kg 
body/ day for 8 weeks. Injections sites were altered on a weekly basis from the nape of the 
neck to mid posterior of the thoracic region of the animal to prevent discomfort and localized 
inflammation. The final injection was delivered 24 hours prior to killing for endpoint sample 
collection. The method was adapted from Stojkovski, Mitrov, & Mladenov (2015), in that the 
dosage used was decreased from 300 mg/kg/day to 250 mg/kg/day, to achieve a somewhat 
less severe level of chronic oxidative stress. The period of induction was also reduced to 8 
weeks instead of 10 weeks to assess an earlier time point, which would be prior to the 
previously reported onset of overt pathology (neurodegeneration) (Stojkovski, 2015).     
Week: 1 0 11 3 2 
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3.3.2 Antioxidant supplement    
The grape seed polyphenol (GSP) supplement used in this study (Oxiprovin, Brenn-o-kem Pty 
Ltd, Tulbagh, South Africa) was derived from grape seed of Vitis vinifera and consists of 45% 
proanthocyanidin B and less than 5% monomers, with the residue made up by long-chain 
sugars and glycosides attached to the polyphenolic oligomers such as catechin and 
epicatechin. GSP was dissolved in distilled water at a concentration of 100 mg/ml and added 
to a gelatin and raspberry jelly mixture (1:10) to form a solid block and fed directly to the 
animal. GSP-supplemented rats were supplemented with 100 mg/kg GSP once daily for the 
duration of the 6-week protocol. All placebo animals received a jelly block with added water 
instead of supplement solution. For rats also treated with D-galactose, a wash-in period of 2 
weeks was allowed for GSP before D-galactose injections were initiated.  The final 
supplementation dose was administered 24 hours prior to the protocol endpoint. 
3.3.3 Sample collection and initial processing 
Body mass and overall wellness were assessed daily. After 8 weeks of D-galactose (or vehicle) 
injections (i.e. at the end of week 11), rats were killed by inhalation of isoflurane at 4%. Aortic 
puncture was performed to extract blood into EDTA and heparin anticoagulated Vacutainer® 
tubes (BD Systems, Plymouth, UK). Tissue samples were excised, weighed and stored for 
further analysis. EDTA anticoagulated whole blood was centrifuged at 3000 rpm for 10 
minutes where after plasma and buffy coats were collected and stored at -80˚C. Neutrophils, 
peripheral blood mononuclear cells (PBMCs) and plasma were isolated from heparin 
anticoagulated whole blood using density centrifugation with Histopaque®-1077 (Cat # 
10771-100ML, Sigma-Aldrich) where after they were separated from erythrocytes using 5% 
(w/v) Dextran(Sigma) sedimentation for 45 minutes. Neutrophils were washed with cold 
sterile PBS and resuspended at 2x106 cells/ml in RPMI 1640 (with glutamate and phenol red, 
Sigma) media for chemokinesis assessment. PBMCs and plasma were stored at -80˚C 
(Appendix B). 
The whole brain, whole liver, visceral adipose tissue and mesenteric lymph nodes were 
excised. Samples were snap frozen using isopentane and immediately submerged in liquid 
nitrogen, where after they were stored at -80˚C. Samples intended for histological analysis 
were stored in 4% buffered formalin solution.   
Tissue samples collected for oxidative stress analysis were weighed and homogenized in cold 
10mM phosphate buffered saline (pH 7.2) at appropriate ratios: for liver 100 mg/mL and for 
adipose tissue 500 mg/mL. Brain tissue was homogenized in cold 50mM Tris–HCl buffer (pH 
7.4) in a 100 mg/mL ratio. Tissue was mechanically homogenized and centrifuged at 10,000 x 
g for 15 min at 4℃ (Appendix F). Supernatants were aliquoted and stored at -80˚C until 
assayed.  
3.3.4 Oxidative stress analysis  
Oxidative stress status was assessed by various assays measuring free radicals, oxidative 
damage and antioxidant capacity in plasma. Hydrogen peroxide levels were assessed as 




ROS/RNS Assay Kit (Cell BioLabs) and following the manufacturer’s protocol (Appendix J).  
Oxidative damage was measured using the Thiobarbituric acid reactive substances (TBARS) 
assay which measures the lipid peroxidation product, malondialdehyde (MDA). The method 
used was an adapted method as used by Varshney and Kale (1990) (Appendix G). Briefly, the 
adaptation entails the addition of butanol and saturated sodium chloride, as the MDA-TBA 
complex formed performs best under acidic conditions. Absorbance was read at 532 nm (with 
a reference wavelength of 572 nm) using a SPECTROstar Nano® absorbance plate reader 
(BMG Labtech, Ortenberg, Germany). Ferric Reducing Antioxidant Power (FRAP) was assessed 
using the method as previously described (Benzie, 1996) (Appendix H). The method used to 
measure total antioxidant capacity was the Trolox Equivalent Antioxidant Capacity (TEAC) 
assay  (Miller, 1993) (Appendix I).  
3.3.5 Evaluation of inflammatory profile  
The inflammatory profile of plasma was expressed in terms of inflammatory cytokine profile, 
as assessed using a Milliplex Rat Expanded Cytokine Magnetic Bead panel (RECYTMAG-65K-
05; Merck Millipore; Darmstadt, Germany). MCP-1, IL-4, IL-1β and IL-10 levels were assessed 
following the manufacturers protocol, with the following CV% for each analyte: MCP-1, 2.3%; 
IL-4, 3.1%; IL-1β, 3.6% and IL-10, 3.8%. Assay kit lower limits for the linear standard curve was 
29.3, 4.9, 2.4 and 7.3pg/ml for MCP-1, IL-4, IL-1β and IL-10 respectively. 
The chemokinetic efficacy of neutrophils was assessed by tracking movement of cells along a 
chemotactic gradient in a Dunn chamber for 30 minutes, using fMLP (N-FORMYL-MET-LEU-PHE 
F3506, Sigma, USA) as chemotaxin. The method first described (Sapey et al., 2014), was 
adapted in our laboratory previously (Petersen et al., 2018) and was reproduced for the 
results reported here. Live cell microscopy was performed and recorded on the Olympus Cell 
system IX-81 inverted fluorescent microscope system, with F-view cooled CCD camera and 
using Soft Imaging Systems software. Images were then analysed using Image J (Java 
Software) with the Mtrack J plugin (Appendix C). 
3.3.6 Adipose inflammatory status  
Adipose tissue inflammatory status was assessed by measuring levels of myeloperoxidase 
(MPO) and two adipokines, namely resistin and visfatin, using commercially available rat 
resistin (RTEN) ELISA kits (E-EL-R0614, Elabscience), rat visfatin (VF) ELISA kits (E-EL-R1067, 
Elabscience) and a MPO colorimetric assay kit (E-BC-K074, Elabscience) (Appendix D). Adipose 
tissue was mechanically ground after being submerged momentarily in liquid nitrogen. 
Thereafter samples were homogenized with ice cold PBS in a 550 mg:1000 ml ratio. Adipose 
tissue homogenates were centrifuged at 10,000 x g for 15 min at 4˚C where after supernatants 
were collected and stored at -80˚C. Protein concentration was measured using a Direct 
Detect® Infrared Spectrometer (Merck, Germany) and the Direct Detect assay-free cards. 
Homogenate MPO and adipokine levels were assessed using the manufacturer’s protocols for 
each assay and absorbances read on SPECTROstar Nano® absorbance plate reader (BMG 
Labtech, Ortenberg, Germany) at 450 nm for ELISA assays and 460 nm for the MPO assay. 




3.3.7 Histological analysis 
As mentioned, excised organs were fixed in 4% buffered formalin for a minimum of 3 days, 
before they were impregnated with and embedded into paraffin wax using an automated 
carousel system which dehydrates tissue with descending grades of alcohol, thereafter 
clearing the tissue with xylene and impregnating tissue with molten paraffin wax. Tissue was 
sectioned on a microtome into 5 nm slices and floated onto glass slides. Hematoxylin and 
Eosin (H&E) stains were performed on mesenteric lymph nodes using standard procedures. 
Slides were mounted using mounting media (DPX, 06522, Sigma-Aldrich, USA). Tissue sections 
were visualized at 100x magnification using a bright-field microscope (Nikon Eclipse E400) and 
images captured with a mounted camera (Nikon DS-Fi2) fitted with a digital sight processor 
(DS-U3, Nikon, Japan).  
3.3.8 Absolute PBMC telomere length analysis 
Peripheral blood mononuclear cells (PBMCs) were isolated from whole blood anticoagulated 
with EDTA. PBMCs were resuspended in phosphate buffered saline and a DNeasy blood and 
tissue kit (Qiagen) was used to isolate DNA from cells according to manufacturer guidelines 
with slight modifications. Cells were lysed in the lysing buffer overnight in a water bath at 
56˚C before being washed and eluted. Thereafter isolated DNA was resuspended in 50ml 
elution buffer. DNA integrity and concentration was quantified using the Xpose™ Touch & Go 
reader (Trinean, Belguim) and Drop Sense 16 software (Appendix E). DNA (20ng/µl) was 
amplified using KAPA SYBR® FAST qPCR Master Mix (2X) Kit (Merck, Darmstadt, Germany), 
using the primers presented in Table 3.1.  
Real time qPCR was used to measure absolute telomere length using the StepOnePlus™ Real-
Time PCR System (Applied Biosystems, USA). The method first described by O’Callaghan and 
Fenech (2011) was modified for rat PBMCs by using 2 x106 cells/ml. Cycling conditions for the 
reaction on StepOnePlus™ Real-Time PCR machine were as follows: pre-incubation of 10 min 
at 95°C, followed by 40 cycles of 95°C for 15 sec, 60°C for 15 sec and 72°C for 10 sec (Appendix 
K).    
Standard curves were set up using telomere and 36B4 (reference gene) standards and 
primers, as presented in the table below. All samples were amplified in triplicate and mean 
cycle time (Ct) values were used in subsequent calculations. All standards and primers were 





 OLIGOMER NAME SEQUENCE (5’-3’) AMPLICON 
SIZE 
STANDARDS    
 Telomere standard (TTA GGG)14 84 
 36B4 standard  CAG CAA GTG GGA AGG TGT AAT CCG TCT CCA CAG ACA AGG 
CCA GGA CTC GTT TGT ACC CGT TGA TGA TAG AAT GGG 
75 
PRIMERS     
 Telomere forward CGG TTT GTT TGG GTT TGG GTT TGG GTT TGG GTT TGG GTT  39 
 Telomere reverse GGC TTG CCT TAC CCT TAC CCT TAC CCT TAC CCT TAC CCT  39 
 36B4 forward  CAG CAA GTG GGA AGG TGT AAT CC 23 
 36B4 reverse  CCC ATT CTA TCA TCA ACG GGT ACA A 25 
  
Table 3.1. Primers and standards utilised to determine absolute telomere length of PBMCs.  
3.3.9 Statistical analysis  
Statistical analyses were performed using GraphPad Prism (version 8.0.2). The normality of 
data sets was assessed using the Shapiro-Wilk test. Normally distributed data sets were 
compared using two-way ANOVA and Fishers LSD post hoc tests. Non-parametric data sets 
were compared using Kruskal-Wallis and Dunn’s post hoc tests. The level of statistical 






3.4.1 Body and organ mass 
All experimental groups on average gained body mass at a similar rate over the course of the 









Figure 3.2: Change in average body mass gained over the ten-week duration of the study. Data is presented as 
means for body mass per group (n=10 each) at weekly intervals. Error bars indicate standard deviations. NP – 
normal placebo, NG – normal grapeseed, AP – ageing placebo, AG – ageing grapeseed. 
Organ masses for all animals were recorded at the end of the study protocol and after 
dissection. There were no significant differences in organ masses between experimental 



































Table 3.2: Average organ masses at protocol endpoint measured in grams (n=10 per group). Data is presented 
as means and standard deviations NP – normal placebo, NG – normal grapeseed, AP – ageing placebo, AG – 
ageing grapeseed, IN. LYMPHS -intestinal lymph nodes, GASTROC – gastrocnemius, EDL - Extensor digitorum 
longus, (L) – left, (R) – right.   
3.4.2 Qualitative observations 
The frailty index assessment tool recently described (Yorke et al., 2017) is a comprehensive 
way of quantifying clinical ageing. Although the time point of sample collection was too early 
in the ageing process to make full use of this tool, some qualitative assessments in line with 
this tool were recorded. For example, all D-galactose-treated placebo animals (but not those 
also treated with GSP) exhibited poorer coat quality and mild piloerection at the end of the 
protocol, when compared to control animals. This clinical indication of early ageing was also 
reflected at tissue level. Representative H&E images of mesenteric lymph nodes (Figure 3.3 
A-D) depict the changes in ultrastructure with D-galactose-induced ageing, as well as the 
preventative effect of GSP. In frame A, an image of a mesenteric lymph from a control rat 
exhibits a homogenous ultrastructure with clear, circular follicular formation, minimal 
 
NP NG AP AG 
 
mean (SD) mean (SD) mean (SD) mean (SD) 
BRAIN 1,87 (±0,07) 1,90 (±0,07) 1,91 (±0,09) 1,90 (±0,09) 
NECK FAT PAD 0,81 (±0,29) 0,83 (±0,27) 0,77 (±0,27) 0,77 (±0,21) 
HEART 0,90 (±0,10) 0,95 (±0,07) 0,98 (±0,08) 0,98 (±0,08) 
SPLEEN 0,60 (±0,06) 0,69 (±0,09) 0,71 (±0,09) 0,70 (±0,08) 
LIVER 10,73(±1,05) 10,82 (±0,73) 11,47 (±0,83) 10,87 (±0,97) 
VISERCAL FAT 1,73(±1,06) 2,19 (±0,71) 2,36 (±0,54) 2,60 (±0,69) 
IN. LYMPHS 1,09(±0,39) 0,77 (±0,33) 1,32 (±0,86) 1,06 (±0,49) 
VASTUS 2,12(±0,25) 2,58 (±0,25) 2,58 (±0,26) 2,38 (±0,23) 
GASTROC 1,40 (±0,16) 1,58 (±0,21) 1,64 (±0,18) 1,57 (±0,15) 
SOLEUS 0,23 (±0,05) 0,26 (±0,03) 0,27 (±0,03) 0,26 (±0,03) 
EDL 0,12 (±0,05) 0,11 (±0,02) 0,13 (±0,01) 0,12 (±0,01) 
KIDNEY(L) 1,11 (±0,12) 1,12 (±0,09) 1,18 (±0,15) 1,16 (±0,14) 
KIDNEY(R) 1,11 (±0,12) 1,17 (±0,07) 1,15 (±0,17) 1,18 (±0,08) 
ADRENAL(L) 0,04 (±0,01) 0,05 (±0,01) 0,05 (±0,01) 0,05 (±0,01) 




subcapsular space and few darkly purple stained cells (leukocytes) in the peripheral sinuses. 
A similarly normal picture was evident in groups treated with GSP only (frame B). In contrast, 
in frame C, the mesenteric lymph node of an animal from the D-galactose-induced ageing 
group showed extensive fibrosis disrupting the interior cortical ultrastructure, areas of 
extended subcapsular space and an increased number of leukocytes within the peripheral 
sinuses. In frame D, a mesenteric lymph node from an animal subjected to both D-galactose-
induced ageing as well as GSP supplementation, exhibits general ultrastructure that is very 
similar to that of the control animals, suggesting preventative efficacy of the antioxidant 
treatment. 
 
Figure 3.3:  Representative histological images of the mesenteric lymph nodes from A) a control animal, showing 
very few immune cells in the subcapsular space (white arrows), B) a control animal treated with GSP, C) an 
animal treated with D-galactose, illustrated by abundant cells in the subcapsular space (white arrows) and 
diffuse fibrosis (black arrows) and D) an animal administered both GSP and D-galactose, where normal histology 
with clear follicles are visible. TS indicates the transverse sinuses located between follicles of mesenteric lymph 
nodes. Magnification of 20x was used to capture the images on the left. 
 
3.4.3 Oxidative stress status 
Considering plasma data firstly, there were no significant changes in lipid oxidative damage 
marker MDA (Figure 3.4A) or ROS content (H2O2; refer to supplementary material) in groups 




plasma ascorbic acid equivalent ferric iron reducing capacity (FRAP) was decreased 
significantly in the D-galactose-treated group when compared to the normal control, while 
GSP supplementation increased the antioxidant capacity in the D-galactose-treated group 
towards normal when compared to AP (Figure 3.4B). The GSP supplement tended to increase 
total antioxidant capacity in plasma in both treated groups (NG and AG) when compared to 
their respective controls (Figure 3.4C), with the increase in TEAC for AG reaching statistical 
significance when compared to NP.  
MDA, FRAP and TEAC assays were also conducted on brain and liver tissue samples. No 
significant changes were evident in response to either D-galactose- or GSP treatment (Figure 
3.4 D-I), with the exception of brain TEAC, which seemed slightly higher in both D-galactose-
treated groups, although this effect did not reach statistical significance due to high variability 









































Figure 3.4: Plasma levels of A) TBARS assay measuring MDA, B) Ferric iron reducing power (FRAP) and 
C) Trolox equivalent antioxidant capacity (TEAC). Similar analysis were also performed for brain (D-F) 
and liver (G-I) tissue. Data shown are group means and standard deviations. NP – normal placebo, NG 
– normal grapeseed, AP – ageing placebo, AG – ageing grapeseed.  
A) B) C) 
D) E) 
F) 









































































































































































3.4.4 Inflammatory status 
The accelerated ageing protocol resulted in significant pro-inflammatory (IL-1β) signalling, 
which was reversed in the presence of GSP, with a striking 50% increase in plasma IL-1β levels 
between normal placebo and aged placebo groups (Figure 3.5A). In contrast, plasma MCP-1 
concentration was significantly decreased in response to both D-galactose and/or GSP 
treatment, when compared to the control (Figure 3.5B). IL-10 was significantly decreased with 
D-galactose-induced ageing, and lower in the combined treatment group (Figure 3.5C). IL-4 
















Figure 3.5: Effect of D-galactose-induced ageing and preventative GSP supplementation on plasma 
cytokine concentrations: a) MCP-1, b) IL-4, c) IL-1β and d) IL-10.  Graphs depicted show the group 
means and standard deviations. NP – normal placebo, NG – normal grapeseed, AP – ageing placebo, 
AG – ageing grapeseed. 








































































In terms of neutrophil chemotactic capacity (Figure 3.6), the total and linear distances 
travelled towards a chemotactic signal did not seem to change significantly in response to 
either D-galactose or GSP administration. However, the fact that linear distance decreased by 
a third in the group treated with D-galactose may have clinical significance despite the lack of 
statistical significance. In line with this linear distance as well as total distance was significantly 








Figure 3.6: Neutrophils chemokinetic ability was measured using live cell imaging to track neutrophil 
movement towards fMLP in a Dunn chamber. A) the total distance travelled by neutrophils. B) the linear 
distance covered by neutrophils from starting position to the final position and. Data shown is the group 
means and standard deviations. NP – normal placebo, NG – normal grapeseed, AP – ageing placebo, 
AG – ageing grapeseed. 
 
In terms of absolute PBMC telomere length (Figure 3.7), there were no statistically significant 
changes in absolute telomere length following either treatment. However, there was a trend 
for increased telomere length after supplementation with GSP (ANOVA main effect of 






























































Figure.3.7: PBMCs were isolated from whole blood and DNA extracted which was used to measure 
absolute telomere length using real-time qPCR. Data is represented as kilo bases per genome in box and 
whisker diagrams, data is presented as group average (bars) with standard deviation. NP – normal 
placebo, NG – normal grapeseed, AP – ageing placebo, AG – ageing grapeseed. 
A significant decrease in adipose tissue levels of resistin was observed in animals subjected to 
D-galactose treatment (AP), with a partial preventative effect of GSP (AG) (Figure 3.8A). No 
statistically significant changes were seen in the concentration of visfatin in response to D-
galactose (Figure 3.8B), but in the absence of D-galactose, GSP supplementation tended to 
increase visfatin when compared to the normal placebo (NP) group. No significant differences 
were noted in the adipose tissue levels of MPO between experimental groups, although AG 






Figure 3.8: The inflammatory status of visceral adipose tissue was assessed using ELISA kits; for 
resisitn and visfatin, and a colorimetric assay to measure MPO. a) shows the resistin concentration of 
visceral adipose tissue. Graph b) shows the visfatin levels of adipose tissue. Graph c) shows the MPO 





























































































levels of visceral adipose tissue. Graphs depicted show the group means and standard deviations. NP – 
normal placebo, NG – normal grapeseed, AP – ageing placebo, AG – ageing grapeseed. 
3.4 Discussion 
The main aim of this study was to establish a model of early transition to accelerated ageing 
that is induced by excessive oxidative stress, using daily injections of D-galactose. We aimed 
to assess both suitability and sensitivity of this model in the preventative medicine sphere, 
for the assessment of efficacy of daily supplements in the prevention of oxidative stress-
associated accelerated ageing.  
The results obtained in the current study reflects the complexity of simulating accelerated 
ageing. In particular, early stage ageing, where dysregulation may still be countered by 
antioxidant treatment as a preventative strategy, is extremely difficult to simulate 
convincingly, given the small effect sizes that is to be expected. However, given our 
comprehensive approach in terms of analytical parameters, we are confident that our 
interpretation of results is accurate. 
Firstly, considering the ability to induce systemic accelerated ageing using a somewhat milder 
model than that used to induce Alzheimer-like neurodegeneration (Stojkovski et al., 2015; El-
Baz et al., 2018; Hor et al., 2018; Baradaran et al., 2019), the mesenteric lymph nodes clearly 
reflect an aged histological phenotype in line with a previous report of tissue damage 
associated with ageing, depicted in the mesenteric lymph node using H&E stains (Zolla, 2015). 
Current data suggest that even the milder D-galactose intervention (lower dose and shorter 
duration) already resulted in significant damage at tissue level. The significant fibrosis 
observed in the current study – a hallmark of ageing tissue – suggests that a chronic 
inflammatory response had been activated, as lymph node fibrosis is associated with a pro-
inflammatory immune profile (Thompson et al., 2017; Magnuson et al., 2019).  
The ageing literature suggests the changes in ultrastructure to modulate the maturation of 
various immune cells and their function (Thompson et al., 2017; Turner and Neil, 2017).  
Although immune cell function was not comprehensively assessed in the current study, 
cytokine data is in line with an interpretation of a relatively aged lymph node after D-galactose 
treatment. Indeed, the plasma cytokine profile (increased IL-1β and decreased IL-4 and IL-10) 
is suggestive of chronic low grade inflammation, in line with reports on hyperactivity of the 




Li, 2018; Nam, 2019). In addition, the neutrophil chemotactic activity assay illustrates a more 
than 30% decrease in neutrophil linear distance despite unchanged total distance travelled in 
response to a chemotactic stimulus. This is suggestive of decreased neutrophil directional 
accuracy, as previously reported in neutrophils of aged individuals (Sapey et al., 2014; 
Petersen et al., 2018). These small but statistically significant changes in the inflammatory 
profile is suggestive of the gradual, cumulative maladaptive inflammatory changes resulting 
from chronic oxidative damage and which eventually leads to immunosenescence and a 
compromised aged phenotype (McEwen, 1998). However, given the relatively early endpoint 
for sample collection in the current study, a longer duration longitudinal study is required to 
fully substantiate this interpretation. Nevertheless, the cytokine profile is in line with a switch 
to an early pro-inflammatory phenotype. 
Our data showing no effect on MCP-1 levels further supports our interpretation of an early 
pro-inflammatory phase of maladaptation. Increased plasma MCP-1 levels are commonly 
reported in chronic low grade inflammation in obesity, where it is secreted by resident 
macrophages within the adipose tissue (Ahima, 2009; Tchkonia, 2010) , and in models of 
advanced inflammation-associated neurodegeneration (Powrie, 2018). The fact that MCP-1 
levels were not yet increased in the current study suggests that the pro-inflammatory shift 
has not yet resulted in the significant neuroinflammation characteristic of the more severe D-
galactose model, or sufficient macrophage infiltration into adipose tissue – the latter is 
further supported by our analysis of adipose chemokines, which reflects no detrimental 
changes in either resistin, visfatin or myeloperoxidase. Together, this picture is in line with an 
early maladaptive state.  
The changes in inflammatory status in the D-galactose model has been demonstrated to be 
the result of oxidative damage (Sadigh-eteghad, 2017), as already mentioned. However, given 
the picture of very early pro-inflammatory changes in the current study and the existence of 
several endogenous antioxidant systems, it is realistic to expect that not all redox assays will 
reflect damage at this early stage, as at least some antioxidant counter mechanisms should 
still be sufficiently functional to neutralise oxidative stressors to an extent. 
This was indeed the case. Previous reports of redox changes in more severe D-galactose 
models include significant oxidative stress (increased ROS, MDA and and Acetylcholinesterase 




(SOD), FRAP, glutathione (GSH) levels) in brain tissue of experimentally aged (500 mg D-
galactose/kg body mass for 6 weeks) rats when compared to age-matched controls (Garg, 
2016). In a similar study by a different research group, circulatory measures demonstrated 
similar changes in redox status in serum and liver, as reflected by increased oxidative damage 
(MDA and H2O2) and decreased antioxidant activity (SOD, catalase (CAT) and glutathione 
reductase (GR)) in rats after administration of 150 mg/kg body mass D-galactose per day for 
10 weeks (Y. Li, 2014). These studies demonstrate that in more severe models, significantly 
compromised redox status reflected in multiple parameters is consistently evident. In 
contrast,  in the current, more moderate model, only plasma FRAP decreased significantly in 
response to  D-galactose treatment, suggesting that other systems, such as the GSH and SOD 
systems, may still be sufficiently functional to prevent large scale cellular oxidative damage 
(e.g. as would be reflected by an increased MDA). We have recently described a similar profile 
in the context of rheumatoid arthritis-associated early accelerated ageing, where plasma 
FRAP (followed by liver FRAP) was again the first indicator of dysregulation (Ross and Smith, 
2020). These data are in line with the literature, where it is commonly accepted that cellular 
damage is only detected after exhaustion of endogenous antioxidant systems (Tan et al., 
2018).   
Lastly in terms of accelerated ageing, the assessment of absolute telomere length in 
peripheral blood mononuclear cells was a particularly novel aspect of this study. Telomere 
length has been proposed as a biomarker of ageing as it dictates the lifespan of a cell (Saretzki, 
2002; López-otín, 2013; Xi, 2013) - once cells reach a crucial shortened telomere length due 
to repeated damage repair cycles, the cell switches to a senescent phenotype which can cause 
cellular stress to surrounding cells and the microenvironment. The results from the real time 
qPCR assessment of absolute telomere length suggests that the extent of accelerated ageing 
has not yet resulted in detectable change to the telomere length of PBMC’s, which is in line 
with the MDA data. While this result indicates that telomere shortening is probably not an 
accurate diagnostic biomarker in the early phases of ageing, it supports our model as a 
simulation of early ageing-associated physiological changes. 
One of the aims of this study was to complete comprehensive whole-body investigation of 
different compartments, which are not normally examined, to elucidate changes which may 




study was the analysis of adipokines in adipose tissue. We report D-galactose-associated 
maladaptation in adipose in the absence of obesity, in the form of decreased levels resistin 
when compared to controls. Resistin is normally responsible for opposing the effects of insulin 
in peripheral tissue, thus promoting chronic disease development (Maebuchi, 2003; Guzik, 
2017). This data has shown that lower levels of resistin are present as well as decreased 
circulating MCP-1. A possible explanation for this may  be lower levels of activated circulating 
immune cells, which translates to a change in inflammatory signalling (Guzik, 2017).  
Turning attention now to the specificity of the model to reflect preventative treatment 
efficacy, it is important to firstly understand the effect anticipated for the chosen treatment 
– in the current study, a grape-derived antioxidant. According to several studies, grape seed-
derived supplements can reduce oxidative stress by reducing free radicals through its ability 
to donate a hydrogen proton as well as quenching singlet oxygen via it’s multiple -OH groups 
(Y. J. Zhang, 2015; Fernandes, 2016) – this would directly reduce ROS levels and reduce 
demands on antioxidant systems (e.g. as indicated by FRAP and TEAC). Coupled with its ability 
to reduce free radical levels, grape seed antioxidants also have significant metal chelating 
properties which serve to reduce lipid peroxidation (Shi et al., 2003; Xia et al., 2010; Aybast 
et al., 2018), thus preventing MDA formation. The grape seed polyphenol investigated in this 
study has also previously been studied and shown to have significant antioxidant and anti-
inflammatory properties by increased oxygen radical absorption capacity (ORAC) - indicative 
of an ascorbic acid-like quenching of hydroxyl ions  by donation of hydrogen protons - in a 
rodent model of muscle damage (Kruger, 2007; Kruger and Smith, 2012; Myburgh et al., 2012; 
Kruger et al., 2014).  
Indeed, plasma FRAP - the only redox parameter in the current study to be significantly 
compromised after D-galactose treatment – was significantly higher in D-galactose-treated 
animals treated with GSP when compared to D-galactose placebo-treated animals, in line with 
literature on similar supplements (Cao, 1998; Fernandes, 2016). In addition, although not 
statistically significant, GSP treatment in both control and D-galactose animals showed a 
consistent tendency to increase plasma TEAC and decrease MDA levels, in line with conferred 
antioxidant economy and decreased cellular damage. Of further significance, again 
independent of D-galactose, GSP treatment also showed a tendency to increase absolute 




polyphenols in different models (Liu, 2012; Petersen, 2016). Furthermore, this result suggests 
that absolute PBMC telomere length - although not accurately reflecting gradual allostatic 
effects of ageing per se – is an accurate indicator of antioxidant efficacy. This is in line with 
reports of improved telomerase activity after treatment with other antioxidant 
phytomedicines (Xiao-bin, 2011; Nisticò, 2015; Thi, 2019). These antioxidant effects were also 
evidenced in lymph node histology, which in GSP-treated D-galactose-exposed animals 
resembled a normal phenotype. However, in contrast to the data on tissue ultrastructure and 
redox changes, the inflammation data is more complex to interpret. 
Combined with the direct improvements in redox status already discussed, GSP 
supplementation also improved certain inflammatory parameters. The ultrastructure of the 
mesenteric lymph nodes displayed limited fibrosis and maintained follicle integrity in the D-
galactose exposed group which were supplemented with GSP, resulting in a similar 
histological profile to that of the normal placebo group. Related to this, the ageing-associated 
decrease in IL-4 levels was prevented by GSP treatment. Together, this suggests beneficial 
outcome in terms of adaptive immune function. When considering the inflammatory system, 
both the decreased linear distance travelled by neutrophils in vitro in response to fMLP and 
the decreased IL-1β levels suggest an anti-inflammatory response of GSP, in line with other 
studies of polyphenols (Liu et al., 2017; Petersen et al., 2018; Ueda-wakagi et al., 2019).  In an 
anti-inflammatory scenario, one would potentially expect to see an increase in circulating 
levels of IL-10 – however, in the current study, IL-10 levels seem to decrease cumulatively in 
response to induced ageing and GSP treatment. These decreases in IL-10 should not be 
interpreted as pro-inflammatory though; NLRP3 inflammasome activation – which leads to IL-
1β production – is known to activate IL-10 as counter mechanism (Ip, 2018), thus the 
significant GSP-associated downregulation of IL-1β production likely also limited the 
activation of IL-10 production as counter mechanism. Of further interest, a recent paper 
suggested a more direct antioxidant effect of IL-10 (Gao, 2020), which in the current study 
was simply not necessary yet at this early stage of dysregulation.  Furthermore, GSP was 
recently reported to reduce the requirement for IL-10 signalling in IL-10 knockout mice (Yang 
et al., 2014),  which further supports our interpretation.  We acknowledge however that a 
more comprehensive assessment of the inflammasome as well as anti-inflammatory 




Going forward, we have identified a few more parameters which may be sufficiently sensitive 
to reflect the early stages of ageing. For example, very recently, primary murine tissue 
cultured in media containing D-galactose showed dose-dependent mitochondrial 
dysfunctional changes after only 48 hours (Gao et al., 2020). Thus, assessment of 
mitochondrial measures such as mitochondrial ROS levels or membrane potential may 
accurately reflect damage at cellular levels already at an early time point in the D-galactose 
ageing model. Similarly, another recently published study illustrated mitochondrial damage 
in murine tissue after 6 weeks of in vivo D-galactose treatment, which was reflected by 
significant decreases (≈25%) in superoxide dismutase (SOD) levels and significantly increased 
H2O2 (indicative of ROS) and 8-hydroxy-2-deoxyguanosine (indicative of DNA damage) levels 
(Du et al., 2020). Although the lowest dose employed in the latter study was already double 
the dose employed in the current study, these parameters should be assessed as potential 
sensitive early indicators in the context of early accelerated ageing. Furthermore, in order to 
elucidate potential mechanisms of ageing modulated beneficially by experimental 
treatments, antioxidant mechanisms could be elucidated in more detail, e.g. by assessment 
of changes in SOD and glutathione peroxidase activity. Together, these recent publications 
indicate not only the fact that mitochondrial markers are sensitive early markers in the 
current context, but also that there currently is an increased interest in the use of D-galactose 
models in research pertaining to all stages of ageing and across a wide variety of specific foci.  
To conclude, current data illustrate the milder D-galactose model to be a suitable pre-
pathology model exhibiting characteristics of early ageing, oxidative stress and inflammation. 
In addition, this model seems suitably sensitive to reflect preventative effects of an 
antioxidant treatment, including potential beneficial effects on absolute telomere length. In 
the context of preventative medicine, we would further recommend that a longitudinal study 
design is applied, so that definitive proof of a delayed onset of the starting point of ageing 
may be generated for new drugs specifically aimed at the preventative medicine niche. 
Extension of the study protocol to include more time points will additionally enable the 
assessment of known age-related deficits such as parameters indicative of central amyloid β 
deposition reported in Alzheimer’s disease (Nakamura et al., 2018) and the frailty index 
developed for ageing studies in rodents (Yorke et al., 2017), to allow for a more 
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Chapter 4: Collagen-induced rheumatoid arthritis-associated accelerated ageing in rats 
 
A truncated version of this chapter has been published in Inflammopharmacology (impact 
factor 3.450). 
Citation reference: Ross, K.S., Powrie, Y.S.L. & Smith, C. Accelerated ageing profile in 
rheumatoid arthritis is unique and tissue compartment specific. Inflammopharmacol 28, 
967–977 (2020). https://doi.org/10.1007/s10787-020-00731-5 
4.1 Abstract 
Rheumatoid arthritis is prevalent in more than 1% of the global population, with highest 
occurrence between ages 35-50, which places a huge burden on the economy. Drug discovery 
for prevention of this chronic disease is therefore a priority. It is known that subclinical 
progression of many chronic non-communicable diseases are exacerbated via accelerated 
ageing, a pro-inflammatory phenotype shift. However, since rheumatoid arthritis additionally 
has significant humoral immune activation, inflammatory signalling – and thus the 
accelerated ageing profile – may differ from other chronic inflammatory diseases. The current 
study simulated rheumatoid arthritis onset in a collagen-induced arthritis (CIA) rodent model, 
to characterise the redox and inflammatory profile at onset of clinical symptoms, in different 
tissues, in the presence and absence of preventative antioxidant treatment. Data illustrates 
that an increased free radical level are evident already very early on in RA disease progression. 
Furthermore, oxidative stress seems to somewhat precede a significant pro-inflammatory 
state, perhaps due to humoral immune activation. Our data across different compartments 
further suggest that the compensatory increase in endogenous antioxidant activity is 
gradually exhausted at a different pace, with the liver showing the first signs of oxidant 
damage, even before significant evidence exist in circulation. Current data further suggest 
that preventative antioxidant intervention may have a sparing effect on endogenous 
antioxidant mechanisms and preserve telomere length to delay disease progression - or at 
least the accelerated ageing known to exacerbate RA symptoms – although it did not seem to 







4.2 Introduction  
Rheumatoid arthritis (RA) is a growing disease burden and the incidence is expected to grow 
over the next ten years because of the increasing size of the global elderly population (Van 
Onna, 2016). With a largely unknown aetiology and robust progression, this autoimmune 
disease is characterised by a complex model of pathology, such as immune cell infiltration 
and proliferation of synovium activated by an auto-immune response, resulting in chronic 
inflammation in the synovial fluid within joints causing pain, stiffness, degradation and 
weakness. Furthermore, whole body effects such as in fatigue, malaise, cachexia, and loss of 
appetite, are also commonly reported.   
Chronic inflammatory diseases in general have many hallmarks in common with ageing and 
are linked to exacerbated symptoms in co-morbid diseases also associated with advanced age 
(Mikuls, 2003), such as dysregulation of redox and inflammatory processes which favour 
oxidative stress (and damage) and a pro-inflammatory phenotype. Given the still poor 
understanding of disease aetiology and the complexity of management of auto-immune 
diseases such as RA and systemic lupus erythematosus (SLE), it is imperative to identify 
preventative strategies by which clinical manifestation of these conditions may be delayed or 
prevented altogether. However, RA is more complex than other chronic inflammatory 
diseases as it directly results from abnormal humoral immune activation, so that the clinical 
phenotype presents with both chronically activated antibody-mediated immunity and chronic 
inflammation. This is an important consideration in RA-related research, as the changes in 
accelerated ageing profile may not follow the same trajectory as in chronic inflammatory 
diseases where antibody production is not chronically activated.  
 In recent years, RA sufferers have increasingly turned to plant-derived adjuvants to alleviate 
disease symptoms without the side effects of conventional medication (Dragos, 2017). Many 
plant-derived supplements display potent antioxidant potential and moderate anti-
inflammatory capabilities, making them ideal for chronic supplementation strategies in the 
context of RA. The World Health Organisation (WHO) Traditional Medicine Strategy 2014–
2023 indeed also outlines the priority that should be placed on research to elucidate best 
practices in this context.  
Many studies on resveratrol (Correâ, 2018; Yang, 2018; Wang, 2019; El-ghazaly, 2020) and 
other phytomedicines (Saleem, 2020) consistently report beneficial clinical outcome in terms 
of RA in the collagen-induced arthritis (CIA) model in rodents, which uses immunisation with 
type II bovine collagen and incomplete Freund’s adjuvant to trigger an auto-immune response 
(Umar, 2012), resulting in inflammatory polyarthritis which has both clinical, immunological 
and pathological features similar to that of human RA.   
Described in this dissertation is a protocol for consistently inducing arthritis in female Lewis 
rats by immunizing them with bovine type II collagen (CII) emulsified in complete Freund's 




Wistar rats. This model is of value not only in defining the underlying pathogenesis of RA, but 
also as a tool for evaluating pharmacological strategies for treating this condition. 
Our group have previously shown that a grape-derived proanthocyanidin extract may be used 
as preventative strategy to delay oxidative stress-related accelerated ageing (manuscript 
under review), due to its anti-inflammatory (Kruger, 2012; Myburgh, 2012; Cásedas, 2017; 
Petersen, 2018) and antioxidant properties (Bagchi, 2000; Pajuelo, 2011; Chedea, 2014).   
Therefore, the aim of this study was firstly to characterise the established rodent model of 
rheumatoid arthritis (Bendele, 1999; Umar, 2012; Oyenihi, 2019) in terms of redox status, 
cytokine signalling and ageing profile (absolute telomere length) -  including both tissue and 
circulatory compartments of the body, to comprehensively elucidate sites of maladaptation 
– and secondly, to evaluate the efficacy of a grape seed-derived proanthocyanidin as 
preventative strategy in the context of RA-associated accelerated ageing.           
4.3 Methods and Materials  
4.3.1 Ethical considerations 
All experimental procedures were conducted in accordance with ethical guidelines set out by 
the Animal Research Ethics Committee of Stellenbosch University with ethical clearance 
(reference number 0146) (Appendix A).  
4.3.2 Experimental groups and housing 
Forty male Wistar rats were obtained from the Stellenbosch University Animal Facility at 6 
weeks old and weighing 200 ± 46.66 gram. Rats were subjected to a 12:12 light dark cycle and 
housed under normal conditions. Animals consumed standard chow and water ad libitum. 
Rats were randomly divided into 4 groups; a normal control group (NP, placebo-treated), a 
normal group which received daily grape seed proanthocyanidin treatment (NG), a CIA group 
treated with placebo (AP) and a CIA group which received daily grape seed proanthocyanidin 
treatment (AG) (n=10 each).  
4.3.3 Collagen-Induced Rheumatoid Arthritis Model 
 The bovine collagen-induced rheumatoid arthritis (CIA) method described by Bendele and 
colleagues (1999) as used to induced rheumatoid arthritis in male wistar rats. Bovine collagen 
type II, incomplete Freund’s adjuvant were obtained from Chondrex Inc., WA, USA. In brief, 
bovine heterologous type II collagen was dissolved in 0.01N glacial acetic acid (2 mg/ml) 
where after an emulsion was prepared using an equal volume of incomplete Freund’s 
adjuvant as per manufacturer instructions. The bovine collagen/Freund’s incomplete 
adjuvant emulsion was gradually injected intradermally at two sites above the tail region of 
each rat. Rats were placed under isoflurane (3%) anaesthesia to conduct injections. Initial 
injections were done on the first day of week 7 and a second booster shot was administered 
7 days later in the same procedure with the exception of only one injection at a site slightly 
above the previous sites. The onset of swelling in rat paws was observed to confirm clinical 





4.3.4 Antioxidant treatment 
Male wistar rats were pre-treated with a grape seed-derived proanthocyanidin (GSP) for 6 
weeks before rheumatoid arthritis was induced and throughout the 3-week protocol. The 
grape seed polyphenol (GSP) supplement (Oxiprovin, Brenn-o-kem Pty Ltd, Tulbagh, South 
Africa) was produced from grape seed of Vitis vinifera and consists of 45% proanthocyanidin 
B and less than 5% monomers. The remaining residue is made up by long-chain sugars and 
glycosides attached to the polyphenolic oligomers; catechin and epicatechin. The GSP 
supplement was dissolved in distilled water at a concentration of 100 mg/ml and added to a 
gelatin and raspberry jelly mixture (1:10) to form a solid block. The blocks were fed directly 
to the individual animal at a dose of 100 mg/kg GSP, once daily for the duration of the protocol 
of 8 weeks. All placebo animals received a jelly block with added water instead of supplement 
solution. The final supplementation dose was administered 24 hours prior to the protocol 
endpoint. 
4.3.5 Sample collection 
Body weights and overall wellness were assessed daily. After week 10 rats were euthanised 
with inhalation of isoflurane at 4% inhalation. Aortic puncture was done to extract blood into 
vacutainer® EDTA and Heparin anticoagulated tubes. Tissue samples were excised, weighed 
and either stored in 4% formalin or for further analysis. Blood drawn was centrifuged and 
separation in plasma, buffy coats and neutrophil isolations. Brain and liver tissues were snap 
frozen and stored at -80°C.  
Tissue samples used for oxidative stress analysis were weighted and homogenized in cold 
10mM phosphate buffered saline (pH 7.2) for liver (100 mg/1mL) and adipose tissue (500 
mg/1 mL). Brain tissue was homogenized in cold 50mM Tris–HCl buffer (pH 7.4) in a 100 mg/1 
mL ratio. Tissue was mechanically homogenized and centrifuged at 10,000xg for 15 min at 4°C 
to obtain the supernatants used for the analyses. Supernatants were stored at -80°C until 
assayed (Appendix F).  
4.3.6 Rheumatoid arthritis confirmation 
To confirm that rheumatoid arthritis was induced, plasma anti-collagen II IgG titre was 
assessed by ELISA kit (Chondrex Inc., WA, USA). The manufacturer’s protocol was followed 
precisely. Joint swelling was monitored as described previously (Oyenihi, 2019).  
4.3.7 Oxidative stress analysis 
Redox status was evaluated using five assays to measure free radicals, oxidative damage, and 
antioxidant capacity in plasma as well as tissue. Hydrogen peroxide free radical levels were 
measured using an OxiSelect™ in vitro reactive oxygen and nitrogen species (ROS/RNS) assay 
kit (Cell BioLabs) following the manufacturer’s protocol (Appendix J). Oxidative damage was 
assessed with the thiobarbituric acid reactive substances assay (TBARS), which measures lipid 
peroxidation product malondialdehyde (MDA). The method used was according to the 
adapted protocol of (Varshney, 1990)(Appendix G). Absorbance was read at 532 nm (with a 
reference wavelength of 572 nm) using a SPECTROstar Nano® absorbance plate reader (BMG 




Ferric iron reducing antioxidant power (FRAP) and total antioxidant capacity equivalent to 
trolox antioxidant capacity (TEAC) assay. FRAP was assessed using the same method as 
described in the paper by (Benzie, 1996) (Appendix H) and TEAC was performed using 
previously established methods (Miller et al., 1993) (Appendix I).  
4.3.8 Inflammatory status 
The inflammatory status as reflected in rat plasma was assessed using a Milliplex rat expanded 
cytokine magnetic bead panel ELISA-based assay kit (RECYTMAG-65K-05; Merck Millipore, 
Darmstadt, Germany). Monocyte chemoattractant protein-1 (MCP-1), interleukin (IL)-10, IL-4 
and IL-1β levels were assessed following the manufacturer’s protocol, with the following 
coefficient of variation (CV) for each analyte: MCP-1, 2.3%; IL-4, 3.1%; IL-1β, 3.6% and IL-10, 
3.8%. Assay kit lower limits for the linear standard curve was 29.3, 4.9, 2.4 and 7.3pg/ml for 
MCP-1, IL-4, IL-1β and IL-10 respectively. 
The chemokinetic efficacy of neutrophils was assessed by tracking movement of cells in a 
Dunn chamber, after being stimulated with fMLP (Sigma) for 30 minutes. This method was 
adapted from an earlier method (Sapey, 2014), as previously reported (Petersen, 2018). Live 
cell microscopy was recorded on the Olympus Cell system IX-81 inverted fluorescent 
microscope system with F-view cooled CCD camera using the Soft Imaging Systems software. 
Images were then analysed using Image J (Java Software) with the Mtrack J plugin (Appendix 
C). 
4.3.9 Absolute PBMC telomere length analysis 
Peripheral blood mononuclear cells (PBMCs) were isolated from whole blood anticoagulated 
with EDTA. PBMCs were resuspended in phosphate buffered saline and a DNeasy blood and 
tissue kit (Qiagen) was used to isolate DNA from cells according to manufacturer guidelines 
with slight modifications. Cells were lysed in the lysing buffer overnight in a water bath at 
56˚C before being washed and eluted. Thereafter isolated DNA was resuspended in 50ml 
elution buffer. DNA integrity and concentration was quantified using the Xpose™ Touch & Go 
reader (Trinean, Belguim) and Drop Sense 16 software (Appendix E). DNA (20ng/µl) was 
amplified using KAPA SYBR® FAST quantitative polymerase chain reaction (qPCR) Master Mix 
(2X) Kit (Merck, Darmstadt, Germany), using the primers presented in Table 4.1.  
Real time qPCR was used to measure absolute telomere length using the StepOnePlus™ Real-
Time PCR System (Applied Biosystems, USA). The method first described by O’Callaghan and 
Fenech (2011) was modified for rat PBMCs by using 2 x106 cells/ml. Cycling conditions for the 
reaction on StepOnePlus™ Real-Time PCR machine were as follows: pre-incubation of 10 min 
at 95°C, followed by 40 cycles of 95°C for 15 sec, 60°C for 15 sec and 72°C for 10 sec (Appendix 
K).    
Standard curves were set up using telomere and 36B4 (reference gene) standards and 
primers, as presented in the table below. All samples were amplified in triplicate and mean 
cycle time (Ct) values were used in subsequent calculations. All standards and primers were 







Table 4.1.: Primers used for determination of absolute telomere length. 
4.4 Results  
Animals were monitored over the ten-week period and all groups gained body mass at a 
similar rate for the duration of the study (data not shown). Organ masses for all groups were 
recorded at the end of the protocol. There were several significant differences in organ 
masses across groups with the induced rheumatoid arthritis and GSP treated group (AG). The 
induction of RA caused increases in visceral adipose and mesenteric lymph node mass in 
comparison to the normal placebo group. Whereas GSP treatment combined with RA 
induction resulted in decreases in subcutaneous adipose (in comparison to both the NP and 
AP groups), liver, visceral adipose and mesenteric lymph node mass in comparison to the NP 
group. GSP with RA resulted in increased spleen mass. These changes depicting the effect of 









SEQUENCE (5’-3’) AMPLICON 
SIZE 
STANDARDS    
 Telomere 
standard 
(TTA GGG)14 84 
 36B4 standard  CAG CAA GTG GGA AGG TGT AAT CCG TCT CCA CAG 
ACA AGG CCA GGA CTC GTT TGT ACC CGT TGA TGA 
TAG AAT GGG 
75 
PRIMERS     
 Telomere 
forward 
CGG TTT GTT TGG GTT TGG GTT TGG GTT TGG GTT 




GGC TTG CCT TAC CCT TAC CCT TAC CCT TAC CCT 
TAC CCT  
39 
 36B4 forward  CAG CAA GTG GGA AGG TGT AAT CC 23 







Table 4.2: Average organ mass in rats after 10 weeks of CIA with and without GSP treatment. The data 
is represented as means and standard deviations (n=10 per group). Statistical analysis: *, statistically 
different from NP p<0.05; and #, statistically different from AP, p<0.05. IN. LYMPHS -intestinal lymph 
nodes, GASTROC – gastrocnemius, EDL - Extensor digitorum longus, (L) – left, (R) – right.   
 
4.4.1 Rheumatoid arthritis confirmation  
Rheumatoid arthritis onset was confirmed in both collagen-treated groups, by significant 












NP NG AP AG 
 








BRAIN 1,87 ±0,07 1,9 ±0,07 1,82 ±0,08 1,86 ±0,08 
NECK 
FATPAD 
0,81 ±0,29 0,83 ±0,27 0,98 ±0,33 0, 54*,# ±0,17 
HEART 0,90 ±0,10 0,95 ±0,07 0,92 ±0,13 0,91 ±0,07 
SPLEEN 0,60 ±0,06 0,69 ±0,09 0,70 ±0,14 0,74* ±0,09 
LIVER 10,73 ±1,05 10,82 ±0,73 9,87 ±1,38 8,87* ±1,20 
VISERCAL 
FAT 
1,73 ±1,06 2,19 ±0,71 2,36* ±0,65 1,19* ±0,38 
IN. LYMPHS 1,09 ±0,39 0,77 ±0,33 1,35* ±0,43 0,74* ±0,48 
KIDNEY(L) 1,11 ±0,12 1,12 ±0,09 1,06 ±0,11 1,07 ±0,08 
KIDNEY(R) 1,11 ±0,12 1,17 ±0,07 1,07 ±0,11 1,05 ±0,12 
ADRENAL(L) 0,04 ±0,01 0,05 ±0,01 0,04 ±0,01 0,05 ±0,01 
ADRENAL(R) 0,04 ±0,01 0,05 ±0,01 0,04 ±0,01 0,05 ±0,01 




















Figure 4.1: Plasma anti-collagen IgG titre in CIA rats with and without GSP preventative treatment. 
Graphs are means and standard deviations (n=10 per group) 
Representative images of the hind paws of rats after the induction of collagen-induced 
rheumatoid arthritis illustrate significant joint swelling and erythema in CIA (Figure 4.2).  










Figure 4.2: Representative images of right hind paws of rats a) before and b) after induction of collagen 
induced rheumatoid arthritis.  
 
4.4.2 Oxidative stress analysis  
In terms of redox status as reflected in the circulation, there was a significant increase H2O2 
in both RA groups as shown in Figure 4.3. This increase was exacerbated by the 










Figure 4.3:  graph showing results of the OxiSelect assay which measured the levels of H2O2 radicals in 
the plasma for all groups. Graphs depicted show the group means and standard deviations. 





















There was a significant decrease in plasma lipid peroxidation marker MDA (Figure 4.4a). In 
terms of plasma antioxidant capacity (Figure 4.4b&c), only FRAP seemed to be affected by RA, 
although the decrease only reached statistical significance in AG (Figure 4.4b), suggesting a 
cumulative effect of RA and GSP.  
In the liver, MDA was significantly higher in AC, but not AG, when compared to control (Figure 
4.4d). Both FRAP and TEAC seemed slightly reduced in AC, and at least in part corrected by 
GSP, although not all differences reached statistical significance (Figure 4.4e&f). In the brain 
itself, there were significant changes in brain tissue redox status. In line with results in 
circulation, MDA was again decreased in both RA groups when compared to the control. In 
terms of antioxidant capacity, in contrast to findings in circulation, both FRAP, and TEAC were 
increased in both RA groups, independent of GSP, when compared to the normal control 



















































Figure 4.4: a) TBARS assay measuring MDA, b) Ferric iron reducing power (FRAP) and c) Trolox 
equivalent antioxidant capacity (TEAC) of plasma comparing all groups. Images d-f) MDA, FRAP and 
a) b) c) 
d) e) f) 
g) h) i) 







































































































































































TEAC of liver tissue. Graphs g-i) MDA, FRAP and TEAC of brain tissue. Data shown are the group means 
and standard deviations.  
 
4.4.3 Inflammatory status 
In terms of neutrophil chemotactic capacity, the total distance travelled towards a 
chemotactic signal was significantly increased in response to rheumatoid arthritis induction, 
which was partly attenuated by GSP supplementation (Figure 4.5a). Linear distance followed 









Figure 4.5: Neutrophils chemokinetic ability was measured using live cell imaging to track neutrophil 
movement towards fMLP in a Dunn chamber. The graphs depict a) the total distance travelled by 
neutrophils. b) the linear distance covered by neutrophils from starting position to the final position. 
Data is displayed as average micrometer per group and standard deviation.   
 
When investigating the circulating inflammatory cytokines, we found that although there 
were no statistical differences in IL-1β, there was a tendency for this pro-inflammatory 
cytokine to increase when RA was induced (Figure 4.6a). While MCP-1 did not seem to 
respond to grapeseed supplementation or the induction of rheumatoid arthritis (Figure 4.6b). 
IL-10 plasma concentration was significantly increased when rheumatoid arthritis was 
induced in animals when compared to normal (NP) and grapeseed control (NG). GSP 
supplement while rheumatoid arthritis was induced decreased the level of Il-10 back to a 
concentration similar to control (NP and NG) levels (Figure 4.6c). IL-4 is significantly decreased 













































































Figure 4.6: Inflammatory cytokines were assessed using a Multiplex assay measuring plasma 
concentrations of the following cytokines: a) IL-1β, b) MCP-1, c) IL-10 and d) IL-4.  Graphs depicted 
show the group means and standard deviations. 
Grapeseed supplementation combined with the induction of rheumatoid arthritis significantly 
increased telomere length in comparison to the normal placebo control (Figure 4.7). There 
were no notable differences between arthritis induced groups, but the telomere length was 
conserved to a similar extent as that observed after grapeseed supplementation under 
normal conditions.  
a) b) 
d) c) 














































































Figure 4.7: PBMCs were isolated from whole blood and DNA extracted which was used to measure 
absolute telomere length using real-time qPCR. Data is represented as kilo bases per genome as 
mean and standard deviation.  
4.5 Discussion  
Rheumatoid arthritis activates both the innate and humoral immune systems and is 
characterised by significant oxidative damage. The major aim in the current study was to 
investigating the redox and inflammatory profile of this model of early RA development in 
order to elucidate preventative strategy targets specific to RA. A secondary aim was to 
evaluate potential modulatory effects of a grape seed-derived polyphenol supplement as a 
preventative modality in rheumatoid arthritis.  
Successful experimental induction of RA was confirmed in rats by observation of clinical 
symptoms such as joint swelling and erythema, as well as significantly increased plasma levels 
of rat anti-collagen IgG antibodies, in line with other studies using this model (Bendele, 1999; 
Oyenihi, 2019). 
Several studies in animal models of RA have reported altered redox status (Oyenihi et al., 
2019; Stamp et al., 2012; Vasanthi et al., 2009) that is characterised by increased free radicals, 
increased oxidative damage markers and decreased antioxidant capacity. In the current 
study, we expand on the literature by assessments of these parameters in both the circulatory 
compartment and muscle tissue. Furthermore, we employed a time point early in disease 
development and induced RA only after animals have reached adulthood.  By taking this 
approach, we were able to demonstrate a protocol ideally suited for the study of preventative 
strategies, as we were able to perform sample collection at a time point in disease 
development that was early enough to reflect activity of endogenous compensatory 
mechanisms, and only early markers of damage that were compartment specific. 
Our model differs from results reported in more severe, or longer duration, protocols. For 
example, we report significantly decreased levels of plasma MDA in animals with induced RA 



























when compared to controls. Two factors potentially contributed to this finding. Firstly, we 
have chosen a relatively early sampling time point, at 21 days after experimental induction of 
RA. Although other groups have reported increased oxidative damage at this early time point, 
they used different strains of rodents and females, who have been reported to be more 
sensitive to RA induction (Ibraheem, 2013; Wilson-Gerwing, 2013). Several studies using a 
longer experimental protocol have reported increased MDA (Choi, 2006; Vasanthi, 2009; 
Umar, 2013) suggestive of established and chronic oxidative damage, although more 
comprehensive redox status assessments yield varied results in the hands of different 
research groups (Choi, 2006; Zhang, 2008; Arntz, 2015; Oyenihi, 2019). Together, this data 
indicates the importance of comprehensive model characterisation and optimisation, as well 
as the importance of inclusion of both genders in drug discovery investigations.  Secondly, the 
age of the animals was likely another contributing factor in the milder disease outcome in the 
current study. We chose to induce RA in animals at 12 weeks of age, to allow for rats to reach 
adulthood and develop fully functional immune systems and endogenous antioxidant 
defences (Holsapple et al., 2003). In our opinion, this is a more accurate choice for simulation 
of RA that other studies who commonly induce RA at ages from 6-8 weeks (Choi, 2006; Zhang 
et al., 2008; Ibraheem et al., 2013), when rats have barely reached adolescence (Sengupta, 
2013). Given the generally poor translation of results from rodent models – and in particular 
in the preventative medicine niche - into human ones (Smith, 2018), it is imperative that 
animal simulations of disease mimic patient demographics as closely as possible, to maximise 
accuracy of results obtained. 
Using adult animals and a time point early after clinical onset of RA symptoms, oxidative 
damage was not yet detectable in circulation, although oxidative stress was indeed clearly 
present, as is evidenced by the increased plasma hydrogen peroxide levels. Oxidative damage 
was at this stage likely prevented due to endogenous antioxidant systems being able to 
attenuate the damage caused by free radicals in specific tissue compartments. This 
interpretation is supported by the increased antioxidant capacity (TEAC), suggesting that an 
upregulation of endogenous antioxidant activity was still effectively ameliorating lipid 
peroxidation. This is in line with a report in human patients, where significant increases in 
antioxidant capacity was reported in combination with significantly increased levels of 
hydrogen peroxide (Veselinovic, 2014).  Interestingly, increases in circulatory hydrogen 
peroxide levels has been noted in ageing literature as well (Giorgio, 2007), where this increase 
in oxidative stress is known to be a by-product of the inflammatory process. This suggests that 
already this early in RA disease development, accelerated ageing has a significant role, 
suggesting the potential of an antioxidant strategy in this context. Of further interest, in the 
current study a decreased MDA and somewhat increased antioxidant capacity (FRAP and 
TEAC) was reported in the brain, while an opposite profile was present in the liver. This 
suggests on the one hand that early on in disease, the brain is exhibiting superior anti-
inflammatory capacity, and on the other, that the liver is a sensitive early tissue indicator of 
oxidative damage (or prevention thereof) and thus most useful as investigative target for RA 




beneficial effects of the polyphenol supplement, is in line with previous research which 
proposes, that the significant risk for dementia in RA patients (Ungprasert, 2016) may be able 
to be delayed by antioxidant intervention starting very early in disease progression. 
Turning attention now to the inflammatory signalling in RA, concentrations of a variety of 
cytokines were evaluated to gain insight into different branches and functions of the immune 
system.  Although significantly high levels of the macrophage chemoattractant MCP-1 are 
present in the synovium of RA patients (Szekanecz, 1998), and IL-1β is released as pro-
inflammatory chemoattractant from damaged tissues, both plasma MCP-1 and IL-1β levels 
were similar to controls in the current study, suggesting that oxidative damage precedes a 
significant inflammatory response in RA aetiology, or that pro-inflammatory secretion may 
occur only localised in affected tissue at this point.  
In terms of cytokines directly linked to RA progression, increased levels of IL-10 and IL-4 are 
implicated in the disease progression (Vervoordeldonk, 2002). Although IL-10 is commonly 
accepted to have anti-inflammatory effect, such as facilitating downregulation of TNF-α 
secretion, it has also been shown to activate the inflammasome and exacerbate rheumatoid 
arthritis (Greenhill, 2014). This is in line with current data, which reflects an increased IL-10 in 
RA animals. Significantly, this increase was prevented by polyphenol treatment, which has 
been reported to downregulate the action of the inflammasome (Liu, 2017). IL-4 is vitally 
important to stimulate the production of antibodies and its presence in synovial fluid has been 
linked to protection of cartilage against degradation (Van Roon et al., 1996; Park et al., 2017). 
Plasma IL-4 was significantly decreased in RA groups, which may suggest that IL-4 secretion 
has not yet been significantly upregulated despite the significant presence of auto-immune 
antibodies detected in circulation. It is also possible that IL-4 production at this point may be 
localised in the synovium, but this remains to be confirmed, as synovial fluid was not analysed 
in the current study.  
In terms of the intervention treatment, GSP supplementation did not affect IL-4 levels, but 
did improve neutrophil chemokinetic mobility. Neutrophils are implicated as one of the major 
role players in the pathogenesis of rheumatoid arthritis (Wright, 2014). In the ageing 
literature, diminished neutrophil capacity to move directly toward a chemotactic signal with 
as little as possible disturbance to surrounding tissue, is implicated as major cause of 
inflammatory tissue damage(Sapey et al., 2014; Petersen et al., 2018) and resulting telomere 
shortening (Petersen, 2016). In the current study, neutrophil chemokinetic accuracy was 
compromised in RA animals (increased total distance and decreased linear distance) – 
however, GSP preventative treatment prevented this detrimental phenomenon. In line with 
this, GSP treatment was associated with a tendency for somewhat longer telomere length. 
Together, these findings suggest specificity of the GSP treatment as anti-inflammatory and 
antioxidant, while it seemed to have little direct effect on antibody production. This suggests 
that although GSP may have significant benefit early in disease to limit oxidant and 




It is evident that there are several similarities between the profile seen in early RA and that 
of oxidative stress-driven accelerated ageing (Van Onna, 2016). The oxidative stress data 
elucidated in this study shows that increased free radicals are evident already very early on 
in RA disease progression. Oxidative stress seems to slightly precede a significant pro-
inflammatory state, although some pro-inflammatory changes are evident as well. Our data 
across different compartments further suggest that the compensatory increase in 
endogenous antioxidant activity (Burton, 2018) is gradually exhausted, with the liver showing 
the first signs of oxidant damage, even before significant evidence exists in plasma. Current 
data further suggest that antioxidant intervention at this point may have a sparing effect on 
endogenous antioxidant mechanisms to delay disease progression - or at least the accelerated 
ageing known to exacerbate RA symptoms.   
In conclusion, current data show that even at the early time point assessed, significant redox 
and inflammatory dysregulation has occurred. Furthermore, a grape seed-derived 
proanthocyanidin antioxidant extract was shown to have preventative benefit in this context, 
although it did not directly modulate the auto-immune response itself. Given the positive 
effects of early antioxidant treatment, it is recommended that RA high risk populations – as 
well as patients with early clinical disease onset – should consider preventative antioxidant 









Chronic disease has become a significant and growing burden on global health systems, and 
the situation is further exacerbated by ever increasing incidence of co-morbidities. This thesis 
highlights the need for suitable models with which to investigate the onset of accelerated 
ageing, i.e. to elucidate the threshold at which homeostatic disturbances caused by stressors 
result in maladaptation leading to clinical disease onset.   Using these tools, candidate 
preventative medicine strategies may be more accurately evaluated. 
Oxidative stress and inflammation have been identified as the main aetiological factors which 
display maladaptation in many chronic diseases and as a result accelerated ageing. It 
therefore seems imperative to investigate a threshold prior to irreversible dysregulation 
which can be targeted with preventative strategies to delay or prevent the onset of 
accelerated ageing and disease. As mentioned, the difficulty of investigating such a threshold 
is that there are not any suitable models which mimic the gradual cumulative maladaptation 
which precedes clinical disease onset via accelerated ageing. Natural (chronological) ageing 
models are resource intensive, and in human studies have multiple uncontrollable 
confounding factors. A second consideration is the ability to do comprehensive multi-
compartment investigations to elucidate tissue specific changes.          
This thesis aimed to investigate the potential of two models to mimic a state of early 
accelerated ageing and to characterise the earliest dysregulatory changes noticeable in 
oxidative stress and inflammation parameters, both before and shortly after clinical disease 
onset. The rationale for this was to identify the most vulnerable mechanisms contributing to 
an unfavourable redox status, which may be targeted for preventative strategies.  
 In addition, the simultaneous execution of these studies ensured rodent conditions were 
consistent and eliminated confounding factors, enabling direct comparison of results 
obtained and a comprehensive investigation of inflammatory and oxidative status.    
Data from the D-galactose study showed an altered redox status in animals exposed to D-
galactose, when compared to normal controls. A novel finding was the decreased FRAP that 
was evident in the absence of detectable damage, confirming that exhaustion of this 
compensatory antioxidant mechanism precedes other signs of dysregulation. This was 
particularly evident in the plasma in the D-galactose study as depicted in the graph below 

















Figure 5.1: FRAP assay measuring antioxidant capacity in the plasma, Data shown are the 
group means and standard deviations. Significant statistical difference of >0.05 is represented 
by *.    
From current data, other antioxidant mechanisms such as represented by TEAC in this data 
set seem to have sufficient capacity to upregulate quenching activity. The TEAC assay 
measures the ability of both water and lipid soluble antioxidants to scavenge the stable radical 
cation ABTSᶧ via donation of an electron or by hydrogen atom donation (Santos-Sánchez, 
2019). FRAP on the other hand measures the capacity of electron-donating antioxidants to 
reduce ferric iron (Fe3+) to its ferrous form (Fe2+). This means FRAP is a more specific 
measure of antioxidants such as CAT and vitamin E, while TEAC takes into account SOD and 
glutathione (Kurutas, 2016). Within the context of this study, this alteration in the capacity of 
FRAP affects the presence of electron unstable radicals which are more prone to damage 
protein and DNA if unquenched. This may suggest that in future studies, parameters which 
measure protein and DNA damage markers may be more useful to detect oxidative stress.  
While the decrease in FRAP alone has been reported previously, it is usually in combination 
with decreases in other antioxidant measures and increases in oxidative damage markers 
such as MDA (Mutlu-Türkoǧlu, 2003; Cebe, 2014). These studies, however, make use of more 
severe disease states or advanced chronological age.   
The animals which received RA intervention had decreased FRAP capacity combined with 
increases in damage markers such as MDA and H2O2, when compared to the normal controls. 
this indicates that decreases in FRAP may an appropriate parameter to assess both pre- and 
early onset maladaptation, even in the absence of damage. 
FRAP may thus be one of the more sensitive, early marker of dysregulation of redox status 
and can potentially be used as a parameter to monitor longitudinally to assess changes in 
redox balance and for intervention, this is especially true if assessed in the appropriate 





















significantly detected in specific compartments opposed to the plasma, showing significant 
decreases in the liver, combined with increased damage marker MDA. In a previous study 
done on skeletal muscle, similar decreases in FRAP and increases in MDA were noted (Oyenihi, 
2019). This tells us that redox status varies in different compartments and monitoring only 
plasma status may be misleading.    
In the RA model, redox status in the brain was opposite to what was observed in the liver; a 
significant increase in FRAP and decrease in MDA. This was the second novel finding, as 
previous studies have not comprehensively assessed antioxidant status within the brain of RA 
induced animals. While previous research has postulated about rheumatoid arthritis 
associated neurodegeneration, the link between damage and oxidative status has not been 
fully elucidated especially within the context of this model. The risk of RA associated  
neurodegeneration has been reviewed previously (Ungprasert, 2016) and this finding 
supports the concept that this may be a later onset secondary pathology which at the stage 
of progression investigated in this study is susceptible to preventative intervention.   
These changes were not observed in the D-galactose model, although upon further 
investigation a second novel finding may give further insight into the compartment specific 
changes which take place prior to detectable damage in the circulatory system. This was the 
damage noted in the mesenteric lymph node morphology as noted in animals subjected to D-
galactose intervention. Ultrastructure changes within the mesenteric lymph nodes of D-
galactose induced subjects even at a pre-pathology onset state indicated that although 
circulatory measures did not display a severe pro-inflammatory state  tissue specific analysis 
suggested that changes had already begun occurring which may lead to consistent low grade 
inflammation. An interesting further direction would be investigating the morphological 
changes which occur in the brain and liver considering the changes seen in these organs in 
both models regardless of circulatory status.    
The importance of compartment specific investigations is highlighted here as the varying 
redox balance indicates the resistance to damage different compartments possess which may 
elucidate the progression of secondary pathologies associated with different disease states.  
There were similarities in findings across models for various parameters which are 
traditionally measured in ageing studies as well as age-related diseases. One of these were 
telomere length which in both studies did not show statistically significant changes, indicative 
of a pre-accelerated ageing phenotype. Changes in telomere length has been noted in studies 
such as Liu et al. (2015) who showed decreased leukocyte telomere length in HIV positive 
patients or Gamal et al. (2018) who showed telomere shortening in RA patients and correlated 
the shortening with disease severity (Liu, 2015; Gamal, 2018). Both these studies measured 
this parameter at a further progression of maladaptation, as to what the aim of this body of 
work was investigating. The measurement of telomere length has however been shown to 
reflect efficacy of antioxidant supplementation and poses as a tool in the context of 




this finding confirms this finding, wherein women supplemented with vitamin D showed 
longer leukocyte telomere(Richards, 2007).  
When investigating the inflammatory status of both models, there was evidence of a low 
grade pro-inflammatory status within animals subjected to either intervention (D-galactose 
and RA) when compared to normal controls. In the RA model, although clinical observations 
and IgG titre confirmed RA onset, the early timepoint indicated that a severe pro-
inflammatory state had not yet been established. In both models the compensatory 
mechanisms within the inflammatory system, such as inflammasome activation indicated by 
IL-10, have changed status when compared to normal. In the D-galactose model IL-10 is 
decreased whereas in the RA model it is increased. In the RA this was an expected result as 
inflammasome activation is exacerbated in rheumatoid arthritis, while in the D-galactose 
model this was not noted suggesting this type of activation of the immune system has not 
taken place as yet.    
Collectively the results of both studies suggest that the circulatory measures for detection of 
oxidative stress and inflammation may not be sensitive enough to detect pre-pathology or 
early pathology changes. This highlights the need for tissue-specific analysis, as displayed in 
the RA model, where oxidative damage and changes in antioxidant capacity was noted in the 
brain and liver before it was evident in circulation. In the D-galactose model changes were 
noted in the lymph node which were not obvious in circulation.  
Further studies are definitely required to further analyse different tissues and time points 
within the progression of cumulative damage to identify the threshold at which compensatory 
mechanisms and acute changes become permanent maladaptations which lead to pathology. 
A longitudinal study which measures redox and inflammatory status at multiple time points 
during progression would be recommended. Parameters to include would be comprehensive 
measures of antioxidant and oxidative damage such FRAP, SOD and the upstream Nrf2 gene 
expression, while damage markers such as protein carbonyls and 8-oxo-2'-deoxyguanosine 
should be included to assess the entire cellular state. Additional inflammatory markers which 
should be assessed should include the activation markers within immune cell types to observe 
the efficacy of cells as well as telomere and telomerase measurements of leukocytes.   
This study also assessed the potential of a grape seed-derived proanthocyanidin (GSP) to 
attenuate the changes in redox and inflammatory status which precedes pathology, to 
elucidate if these models were sensitive enough to reflect these small effect sizes changes of 
preventative treatments.. The GSP used in this research has previously been shown to have 
antioxidant and anti-inflammatory modulatory properties.  
In both studies the GSP increased antioxidant capacity which showed more effect in certain 
tissue types and compartments. This highlights the importance of these measures in 
preventative medicine research as the small effect changes noted may be beneficial when 
screening drug efficacy not only in the circulatory compartment. Similar modulatory effects 




to normal after supplementation and counteract the disturbances to the allostatic load 
caused by the intervention.  
The one result which highlights this is the correction of ultrastructure of the mesenteric lymph 
nodes after supplementation, a finding that would not have been noted unless tissue specific 
analysis was done in the D-galactose model. In the RA study, GSP supplementation resulted 
in longer telomere length, a novel finding which warrants further investigation such as the 
measurement of telomerase, this has been postulated in previous research and would 
enhance the preventative medicine field greatly.  
This study had various limitations which have been important in elucidating requirements for 
future studies. Namely the duration and sampling times; this study measured the progression 
of the D-galactose and RA model at one time point, and while these results have enhanced 
our understanding of the threshold prior to maladaptation, it would be beneficial to have an 
earlier as well as later time point to comprehensively assess the progression. Secondly it 
would beneficial to this research if more tissue types and compartments are investigated, 
much is still unknown regarding the gastrointestinal track, bone, cardiovascular and 
respiratory systems in the context of the D-galactose and RA models, especially at this pre-
onset stage.  
Ideally a longitudinal study approach will be beneficial for future studies, but the research 
presented in these studies has illustrated the potential benefits which are to be gained from 
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Appendix B: Neutrophil Isolation protocol 
 2ml Histopaque1077(room temperature) is pipette into a 15ml falcon tube and then 
double volume (4ml) of blood obtained by aortic puncture collected in heparin 
anticoagulated Vacutainer® tubes (BD Systems, Plymouth, UK) was carefully poured 
onto the Histopaque layer down the side of each tube. 
 Tubes are transferred to the centrifuge machine with swinging rotor 
(Eppendorf,5804R, Germany) and are spun at speed of 652xg for 30 minutes at 21°C, 
1800rpm. 
* Four different layers of blood are formed*  
 Sediment containing neutrophils and erythrocytes (bottom layer) is separated by 
aliquoting out the plasma layer on top thereafter the second layer containing 




 Plasma is aliquoted into 2 ml sterile capped microtubes and frozen at -80°C, aliquot 
PBMC’s into 2 ml sterile capped microtubes and freeze. 
 Sediment is mixed with equal volume of 6%(room temperature) filtered dextran (in 
Normal Saline) and incubated at 37°C for 45 minutes to allow the sedimentation by 
gravity of erythrocytes. 
Plasma  
Buffy coat (containing lymphocytes, monocytes and etc.) 
Histopaque 1077  




 Pellet containing erythrocytes is discarded and the neutrophils rich supernatant is 
collected and mixed with 10ml of PBS. 
 Neutrophil PBS mixture is centrifuged at 290xg for 10 minutes at 4°C, 1500rpm. 
 Supernatant was removed from tube leaving the pellet containing the neutrophils in 
the tube.  
 Washing with 1ml PBS was repeated once or twice depending on the amount of 
erythrocytes present as a contaminant. 
 The final neutrophils pellet was resuspended into desired volume of media to achieve 
the appropriate cell concentration usually 2x10-6 cells/ml. 
 Neutrophil count 
 Aliquot 200µl in 2 ml sterile capped microtubes 
 Run sample on the CellDyne 3700 to determine neutrophil counts. 




Appendix C: Neutrophil chemotaxis assay Protocol 
 
 A Dunn chamber was used to assess the migratory capacity of neutrophils (in terms of 
distance and directional accuracy) toward a chemotaxin.  
 10 µl of neutrophils in suspension were seeded on coverslip and left to adhere for one 
minute. Their migratory capacity up a chemotactic gradient was then assessed by 






 The coverslip with cells was then placed inverted onto chamber and sealed with hot 
wax mixture (Vaseline: Paraffin: beeswax, 1:1:1).  
 The media was then drained out of the outer well using filter paper.  
 The outer well was and filled with the chemoattractant fMLP (N-FORMYL-MET-LEU-PHE 
F3506, Sigma, USA (100 µl solution with HBSS). A gradient was allowed to form for 20 
minutes before imaging.  
 Neutrophil migratory paths were visualized by combining time lapse images taken at 
20X magnification using an Olympus Cell® system IX-81 inverted fluorescent 
microscope system with an F-view cooled CCD camera (Soft Imaging Systems).  
 Images were acquired every 20 seconds for a total time of 20 minutes. Image J (Java 
Software) was used to track the movement of neutrophils and, measure distance 
covered as well as distance from start using the Mtrack J plugin. 
 Neutrophil tracks were quantified by measuring the total distance they moved (from 
point to point) and the linear distance they covered (a straight path from start to 


























Appendix D: Myeloperoxidase (MPO) Colorimetric Assay Kit Protocol 
 
Catalog No: E-BC-K074 
Method: Colorimetric method 
Specification: 100 Assays 
 
Sample preparation: 
5% tissue homogenate sample: 
Weigh tissue and add reagent 2 application solution to ratio weight(g): volume(mL) = 1:9 
Mechanical homogenate the sample in ice water bath. (*don’t centrifuge*) preserve on ice until 
detection.  Store at -80℃ for detection on another day.  
Sample treatment:  
Take 0.9mL of sample and add 0.1mL of Reagent 3 application solution. Mix fully and incubate at 








1) 3mL ddH2O + 0.2mL sample + 0.2mL reagent 5 = 3.4mL  
2) 3.4mL 1) + 0.05mL reagent 8 = 3.45mL  
1)15:1 ratio 
2) 68:1  
Adapted protocol:  
1) 1mL ddH2O + 0.066mL sample + 0.066mL reagent 5 = 1.132 mL  







Appendix E: DNA Extraction Protocol: Qiagen DNeasy Blood and Tissue Kit Protocol 
 
Before starting:  
 Preheat waterbath to 56℃  
 Defrost sample to room temperature  
1. Transfer sample to 1.5 ml sterile capped microtubes.  
2. Centrifuge sample at 8000 rpm in Eppendorf 5804R (Germany) for 5 mins to form cell pellet. 
3. Remove supernatant (first with p1000 tip, then with p200 tip, leaving small amount so as 
to not disturb pellet) and resuspend pellet in 200 ul PBS.  
4. Pipette 20 ul proteinase K into sample and add 200ul buffer AL.  
5. Mix thoroughly by vortexing.  
6. Incubate sample in water bath (in floatie) at 56℃ overnight.  
7. Add 200 ul cold absolute ethanol (96%-10%), mix thoroughly by vortexing. 
8. Pipette mixture into a spin column placed in a 2 ml collection tube.  
9. Centrifuge at 6000xg (8000 rpm) for 1 minute.  
10. Discard flow through and collection tube. 
11. Place spin column in a new 2ml collection tube and add 500ul buffer AW1. 
12. Centrifuge at 6000 x g (8000 rpm) for I minute.  
13. Discard flow through and collection tube.  
14. Place spin column in new 2 ml collection tube and add 500ul buffer AW2. 
15. Centrifuge at 20 000 x g (14 000 rpm) for 3 minutes. 
16. Discard flow through and collection tube.  
17. Transfer spin column to new 1.5 ml sterile capped microtubes. 
18. Elute DNA by adding 50ul buffer AE to the centre of spin column (be sure to pipette elution 
buffer onto entire surface of spin column filter). 
19. Incubate for 2 minutes at room temperature (15-25 ℃). 
20. Centrifuge at 14 000 rpm (max) for 1 minute.  
21. Repeat elution (steps 18-20) with eluant from step 20.  






Appendix F: Protocol: Homogenization of tissue 
 
Brain homogenates Tissue homogenates:  
50mM Tris–HCl buffer (pH 7.4) containing 1.15% potassium chloride  
Tris-HCL buffer (50mM pH7.4): 
 7.80g of Tris + 11.5g KCl dissolved in 800mL dH2O 
 pH to 7.4 with HCL  
 Fill to 1 L with dH2O 
100mg of tissue in 1ml of buffer  
1. 20ml buffer with tissue, homogenize. Add remaining buffer 
2. The homogenates were centrifuged at 10000 x g for 15mins at 4 degrees.  
3. Supernatants were kept at -80 for the assays. 
 
Tissue homogenates: 
1x PBS (pH 7.2) for tissue homogenization  
To make 1L of 1xPBS:  
 8g of NaCl + 0.2g of KCl + 1.44g Na2HPO4 + 0.24g KH2PO4   
 Add 800mL dH2O 
 pH 7.2. with HCL  
 Fill to 1L  
100mg of tissue was placed in 1ml of PBS and homogenized 
1. 20ml buffer with tissue, homogenize. Add remaining buffer 
2. The homogenates were centrifuged at 12000rpm for 15mins at 4 degrees.  











Appendix G: TBARS(MDA) Assay protocol  
 
Reagents: 
1. Absolute ethanol 
2. 2mM MDA standard stock (Must be made fresh*): 
 0.0125408g (12.5408mg) MDA in 20ml 40% ethanol.  
3. 4mM BHT (butylated hydroxytoluene) (Must be made fresh*): 
 0.008814g (8.814mg) BHT in 10ml abs ethanol. 
4. 0.2M ortho-phosphoric acid (OPA) 
5. 0.1M NaOH 
6. 0.11M TBA (2-thiobarbituric acid) (must be made fresh*): 
 0.159g (158.565mg) in 10 mL 0.1M NaOH 
7. N-butanol 
8. NaCl (saturated) 
Standards preparation:  
 MDA (ul of stock) dH2O (ul) Conc 
Std A 1000ul 0 ul 2mM 
Std B 500ul 500 ul 1mM 
Std C 250ul 750 ul 0.5mM 
Std D 125ul 875 ul 0.25mM 
Std E 62.5ul 937.5 ul 0.125mM 
Std F 31.25ul 968.75 ul 0.0625mM 
Std G 15.625ul 984.375 ul 0.03125mM 
Std H 7.8125ul 992.1875 ul 0.015625mM 
Blank 0 1000 ul 0 mM 
Assay Protocol: 
 Add 100µl of sample/stdin into 2 ml sterile capped microtubes 
 Add 12.5µl of 4mM BHT (reagent 4) 
 Add 100 µl of 0.2M OPA (reagent 5) 
 Vortex for 10 secs 
 Add 12.5 µl TBA (reagent 7) 
 Heat at 90°C for 45 mins 
 Put on ice for 2 mins  
 Keep at room temperature for 5 minutes 
 Add 1mL n-butanol (reagent 8) 
 Add 100 µl saturated NaCl (reagent 9) 
 Vortex for 10 seconds  
 Centrifuge at 6000rpm for 5 mins at 4°C  
 Aliquot 300 µl of supernatant (top layer only) into 96 well plate in triplicate 






 Malondialdehyde tetrabutylammonium salt (MDA) 
o Molecular Weight: 313.52 
o 2 mM Stock  
= 0.0125408g (12.5408 mg) MDA in 20 ml abs ethanol. 
 (butylated hydroxytoluene) BHT 
o MW: 220.35  
o 4 mM stock 
= 0.008814 g (8.814 mg) BHT in 10 ml absolute ethanol. 
 ortho-phosphoric acid (OPA)  
o MW: 97.99 
o 0.2M stock 
=9.799 g OPA in 500 ml dH2O 
 Sodium hydroxide (NaOH) 
o MW: 40 
o 0.1M stock  
= 2g NaOH in 500 ml dH2O 
 2-thiobarbituric acid (TBA) 
o MW: 144.15 
o 0.11M TBA stock 






Appendix H: FRAP assay Protocol 
 
1. Reagents preparation 
 Acetate Buffer (300 mM, pH 3.6) 
o In a 1 L media bottle add 1.627 g Sodium acetate, 16 mL Glacial acetic acid (SAARCHEM 
Cat Nr.: 1021000) and distilled water up to 1 L. 
 HCl (0.1M) (SAARCHEM Cat Nr.: 100319 LP) 
o In a 1 L media bottle add 1.46 mL concentrated HCl (32% HCl) and add distilled water 
to final volume of 1L. 
 TPTZ (2,4,6-tri[2-pyridyl]-s-triazine) (10 mM (Sigma Cat Nr.: T1253)) 
o In a 15 mL conical tube, add 0.0093g TPTZ to 3 mL of 0.1 mM HCl (must be prepared 
fresh for on day of assay). 
 Iron (III) chloride hexahydrate (20 mM (F2877)) 
o In a 15 mL conical tube, add 0.054 g FeCl3.6H2O to 10 mL distilled water (must be 
prepared fresh for on day of assay). 
 L-Ascorbic acid (Sigma Cat Nr.: A5960) Standard (1.0 mM) (Vitamin C) 
o Weigh 0.0088 g Ascorbic acid in a 50 mL centrifuge tube and add 50 mL distilled 
water. Mix until dissolved. (Stock solution) 
(Check: In an 2 ml sterile capped microtubes tube, dilute 125 µl of this stock solution with 
1375 µl water to obtain a concentration of 83 µM. This solution should give an absorbance of 
0.830 0.010 at 265 nm.) 
Before starting the analysis the FRAP reagent needs to prepared 
 In a 50 mL conical tube add 30 mL Acetate buffer, 3 mL TPTZ solution, 3 mL FeCl3 solution and 
6.6 mL Distilled water. The solution should be straw colored, if not discard and prepare fresh 
solution.  
 
2. Sample preparation  
 Plasma was collected from whole blood (with EDTA anti-coagulant) after centrifugation and 








3. Standard preparation  
Standards were made up according to the table below in 6x2 ml sterile capped microtubes. 
4. Assay procedure 
 In a clear 96-well plate add 10 l of the blank to wells A1-3. 
 Add ascorbic acid standards #1-5 (tubes B-E) per well in the designated wells (as directed in 
the table above). 
 Add 10 µl of samples (in triplicate) to the wells (B7-H12). 
 Add 300µ of the FRAP reagent to each well with a multichannel pipette. 
 Incubate the plate for 30 minutes in the incubating oven set at 37°C. 
 Run plate on Multiskan plate reader 
5. FRAP Calculations 
Data is expressed as micromoles of Vitamin C equivalents per liter of sample and calculated from a 
standard curve. 









A (Blank) 0 1000 0 A1-A3 
B #1 50 950 50 A4-A6 
C #2 100 900 100 A7-A9 
D #3 200 800 200 A10-A12 
E #4 500 500 500 B1-3 

















Concentration is then calculated as: 
Conc = (average absobance of sample – average absorbance of blank) - the y intercept / the slope of 
























Concentration Vit C (uM)




Appendix I: ABTS (TEAC) ASSAY Protocol 
 
Reagents: 
1. ABTS (2,2’-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) Diammonium salt: 7mM (Sigma 
Cat nr.: A1888).  
a. Weigh 0.0192 g of ABTS (Fridge) in a 15 mL screw cap tube and add 5 mL distilled 
water. Mix until dissolve. Prepare fresh. 
 
2. Potassium-peroxodisulphate: 140mM (Merck Cat Nr.: 105091)  
a. Weigh 0.1892 g K2S2O8 (Reagent rack) in a 15 mL screw cap tube and add 5 mL 
distilled water. Mix until dissolve. Prepare fresh. 
 
3. ABTS mix (This must be done 24 hours before starting the assay): 
a. Add 88µl of the potassium-peroxodisulphate solution to 5 mL of the ABTS solution in 
a 15 mL screw cap tube. Mix well. Leave in the dark at room temperature for 24 
hours before use. 
 
4. Standard (Trolox also known as 6-Hydrox-2,5,7,8-tetramethylchroman-2-carboxylic 
acid):1.0mM (Aldrich Cat nr.: 238831) 
a. Weigh 0.0125 g Trolox in a 50 mL screw cap tube and add 50 mL of Ethanol 
(Saarchem Cat Nr: 2233540LP). Mix until dissolved. Prepare fresh. Use this solution 
as the stock standard. (Check: When diluted 5x with ethanol this solution should give 




a) Ensure that the plate reader is set to read at 734 nm and the temperature is set at 25C. 
 
b) Preparation of standard series – Take 6 2 ml sterile capped microtubes and mark them A-F. 
Add the amount of standard stock solution and diluents to each tube as described in the table 










A 0 1000 0 A1-A3 
B 50 950 50 A4-A6 
C 100 900 100 A7-A9 




E 250 750 250 B1-3 
F 500 500 500 B4-6 
 
c) Trolox standard wells – add 25 l of standard (tubes A-E) per well in the designated wells in a 
clear well plate. 
 
d) Control wells – add 25 l of the control to the wells (B7-B12). 
 
e) Sample wells – add 25 l of sample IN TRIPLICATE to the wells (C1-H12). 
 
f) Dilute the ABTS mix solution with ethanol to read an absorbance of approximately 2 (0.1) 
(Approximately 1ml ABTS mix and 20mL EtOH). Add 300l of this ABTS mix to each well using 
a multichannel pipette. 
 
g) Leave the plate for 30 minutes at room temperature before taking a reading.  
 






Appendix J: OxiSelect ROS/RNS kit Protocol 
 
Reagents: 
1. Priming agent:  250µl 
2. Stabilization solution: 1.5mL 
3. Catalyst (250X): 20µl 
4. DCF-DiOxyQ:   50µl 
5. DCF standard:  100µl 
6. H2O2 :    100µl (8.821M) 
 
Preparation of reagents: 
2. Stabilization solution: 
 1:10 dilution - 1.5mL stabilization solution in 13.5mL of dH2O 
 Vortex, store at 4°C. 
3. Catalyst: 
 1:250 dilution - 10µl catalyst in 2.49mL PBS 
 Vortex, use immediately. 
4. DCFH solution: 
 1:5 dilution - 25µl DCF-DiOxyQ in 100µl priming agent (reagent 1) 
 Vortex, incubate for 30 mins at room temperature.  
 Dilute solution (DCF-DiOxyQ + priming agent) 1:40 -  125µl DCFH in 4.875mL 
Stabilization solution(solution 2). 
 Vortex, store at -20°C for up to 1 week in the dark!   
 
Preparation of DCF standard curve: 
1:10 dilution series of DCF standard in PBS  
Range: 0µm - 10µm 
Standard tubes DCF standard (µl) PBS (µl) DCF conc(nM) 
Blank 0 1000 0 
1 10 990 10000 
2 100 of tube 1 900 1000 
3 100 of tube 2 900 100 
4 100 of tube 3 900 10 
5 100 of tube 4 900 1 
6 100 of tube 5 900 0.1 
 
Standard curve protocol: 




 Read relative fluorescence at 480 nm excitation and 530 nm emission. 
Assay protocol: 
 Pipette 50µl of sample/ standard/ control to wells (in duplicate).  
 Add 50µl of catalyst to each well. 
 Mix. 
 Incubate 5 mins at room temperature. 
 Add 100µl of DCFH solution (solution 4) to each well.   
 Cover 96-well plate (to protect from light) 
 Incubate at room temperature for 30 mins. 









Appendix K: Real time qPCR Protocol 
 
 PBMC’s harvested from neutrophil isolation Appendix B and frozen down at a density 
of 2 x106 cells/ml. 
 DNA used from extraction as detailed in Appendix E 
 DNA concentrations were measured on Xpose™ Touch & Go reader (Trinean, Belguim) 
and Drop Sense 16 software. 
 DNA (20ng/µl) was amplified using KAPA SYBR® FAST quantitative polymerase chain 
reaction (qPCR) Master Mix (2X) Kit (Merck, Darmstadt, Germany), using the primers 
presented in Table 1.  
 
 Standard curves were set up using telomere and 36B4 (reference gene) standards and 
primers 
 Stock solutions for telomere std: 
Stock= 0.06ng/ul (1.18x108 tel std repeats)  
1:10 dilution series =10ul stock +90µl TE buffer 
 Stock solutions for 36B4 std:  
Stock= 0.02ng/ul (2.63x109 tel std repeats)  
1:10 dilution series =10ul stock +90µl TE buffer 
 Stock solutions for tel std forward and reverse primers: 
F=MW: 7.137 made up to 100µM stock 
Working solution =30µl in 240µl H20 
R=MW:7.570 made up to 100µM 




SEQUENCE (5’-3’) AMPLICON 
SIZE 
STANDARDS    
 Telomere 
standard 
(TTA GGG)14 84 
 36B4 standard  CAG CAA GTG GGA AGG TGT AAT CCG TCT 
CCA CAG ACA AGG CCA GGA CTC GTT TGT 
ACC CGT TGA TGA TAG AAT GGG 
75 
PRIMERS     
 Telomere 
forward 
CGG TTT GTT TGG GTT TGG GTT TGG GTT 




GGC TTG CCT TAC CCT TAC CCT TAC CCT TAC 
CCT TAC CCT  
39 
 36B4 forward  CAG CAA GTG GGA AGG TGT AAT CC 23 




 Stock solutions for 38B4 forward and reverse primers: 
F=MW: 7.137 made up to 100µM stock 
Working solution =30µl in 240µl H20 
R=MW:7.570 made up to 100µM 
Working solution =30µl in 240µl H20 
 Cycling conditions: 
StepOnePlus™ Real-Time PCR System (Applied Biosystems, USA) 
1. pre-incubation of 10 min at 95°C,  
2. 40 cycles of 95°C for 15 sec 
3. 60°C for 15 sec  
4. 72°C for 10 sec.    
 Reaction make up: 
KAPA mastermix  5µl 
Forward primer  1 µl 
Reverse primer  1 µl 
Standard/sample 1 µl 
H2O 2 µl 
 
 All samples were amplified in triplicate and mean cycle time (Ct) values were used in 
subsequent calculations.  
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